<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><?DTDIdentifier.IdentifierValue -//ACS//DTD ACS Journal DTD v1.02 20061031//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName ACSJournal-v102.dtd?><?SourceDTD.Version 1.02?><?ConverterInfo.XSLTName acs2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Org Chem</journal-id><journal-id journal-id-type="iso-abbrev">J. Org. Chem</journal-id><journal-id journal-id-type="publisher-id">jo</journal-id><journal-id journal-id-type="coden">joceah</journal-id><journal-title-group><journal-title>The Journal of Organic Chemistry</journal-title></journal-title-group><issn pub-type="ppub">0022-3263</issn><issn pub-type="epub">1520-6904</issn><publisher><publisher-name>American Chemical
Society</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1021/jo502096t</article-id><article-categories><subj-group><subject>Article</subject></subj-group></article-categories><title-group><article-title>Four-Component Bicyclization
Approaches to Skeletally
Diverse Pyrazolo[3,4-<italic>b</italic>]pyridine Derivatives</article-title></title-group><contrib-group><contrib contrib-type="author" id="ath1"><name><surname>Tu</surname><given-names>Xing-Jun</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath2"><name><surname>Hao</surname><given-names>Wen-Juan</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath3"><name><surname>Ye</surname><given-names>Qin</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath4"><name><surname>Wang</surname><given-names>Shuang-Shuang</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath5"><name><surname>Jiang</surname><given-names>Bo</given-names></name><xref rid="cor1" ref-type="other">*</xref><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" id="ath6"><name><surname>Li</surname><given-names>Guigen</given-names></name><xref rid="aff2" ref-type="aff">&#x02021;</xref><xref rid="aff3" ref-type="aff">&#x000a7;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath7"><name><surname>Tu</surname><given-names>Shu-Jiang</given-names></name><xref rid="cor2" ref-type="other">*</xref><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><aff id="aff1"><label>&#x02020;</label>School
of Chemistry and Chemical Engineering, Jiangsu Key Laboratory of Green
Synthetic Chemistry for Functional Materials, <institution>Jiangsu Normal University</institution>, Xuzhou 221116, <country>P. R. China</country></aff><aff id="aff2"><label>&#x02021;</label>Institute
of Chemistry &#x00026; Biomedical Sciences, <institution>Nanjing University</institution>, Nanjing 210093, <country>P. R. China</country></aff><aff id="aff3"><label>&#x000a7;</label>Department
of Chemistry and Biochemistry, <institution>Texas Tech
University</institution>, Lubbock, Texas 79409-1061, <country>United States</country></aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Fax: <fax>86-516-83500065</fax>. E-mail: <email>jiangchem@jsnu.edu.cn</email>.</corresp><corresp id="cor2"><label>*</label>Fax: <fax>86-516-83500065</fax>. E-mail: <email>laotu@jsnu.edu.cn</email>.</corresp></author-notes><pub-date pub-type="pmc-release"><day>22</day><month>10</month><year>2015</year></pub-date><pub-date pub-type="epub"><day>22</day><month>10</month><year>2014</year></pub-date><pub-date pub-type="ppub"><day>21</day><month>11</month><year>2014</year></pub-date><volume>79</volume><issue>22</issue><fpage>11110</fpage><lpage>11118</lpage><history><date date-type="received"><day>10</day><month>09</month><year>2014</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2014 American Chemical
Society</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>American Chemical
Society</copyright-holder><license><license-p>This is an open access article published under an ACS AuthorChoice <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/page/policy/authorchoice_termsofuse.html">License</ext-link>, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.</license-p></license></permissions><abstract><p content-type="toc-graphic"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jo-2014-02096t_0011" id="ab-d31e213"/></p><p>A novel four-component bicyclization
strategy has been established,
allowing a flexible and practical approach to 37 examples of multicyclic
pyrazolo[3,4-<italic>b</italic>]pyridines from low-cost and readily
accessible arylglyoxals, pyrazol-5-amines, aromatic amines, 4-hydroxy-6-methyl-2<italic>H</italic>-pyran-2-one, and cyclohexane-1,3-diones. The polysubstituted
cyclopenta[<italic>d</italic>]pyrazolo[3,4-<italic>b</italic>]pyridines
were stereoselectively synthesized through a microwave-assisted special
[3+2+1]/[3+2] bicyclization with good control of the spatial configuration
of exocyclic double bonds. The novel [3+2+1]/[2+2+1] bicyclization
resulted in 17 examples of unreported pyrazolo[3,4-<italic>b</italic>]pyrrolo[4,3,2-<italic>de</italic>]quinolones. Reasonable mechanisms
for forming two new types of multicyclic pyrazolo[3,4-<italic>b</italic>]pyridines are also proposed.</p></abstract><funding-group><funding-statement><funding-source>National Institutes of Health, United States</funding-source></funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>document-id-old-9</meta-name><meta-value>jo502096t</meta-value></custom-meta><custom-meta><meta-name>document-id-new-14</meta-name><meta-value>jo-2014-02096t</meta-value></custom-meta><custom-meta><meta-name>ccc-price</meta-name><meta-value/></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1"><title>Introduction</title><p>The development of
highly efficient atom- and step-economic synthesis
of multiheterocyclic scaffolds, particularly pyridine ring-containing
ones, is of chemical and biomedical importance and has been actively
pursued in organic and medicinal research for several decades.<sup><xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref2">2</xref></sup> The structurally diverse and intriguing cyclopenta[<italic>c</italic>]pyridine family has been found to exist in monoterpene alkaloids
that are represented by oxerine,<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> actinidine,<sup><xref ref-type="bibr" rid="ref4">4</xref></sup> and aucubinine A and B<sup><xref ref-type="bibr" rid="ref5">5</xref></sup> (Figure <xref rid="fig1" ref-type="fig">1</xref>) that showed significant biological
activities with respect to abortive and animal stimulating effects.<sup><xref ref-type="bibr" rid="ref3">3</xref>,<xref ref-type="bibr" rid="ref4">4</xref></sup> In addition, a variety of synthetic functionalized pyrazolo[3,4-<italic>b</italic>]pyridine system represents a core skeleton of pharmaceutical
heterocycles with many other biological activities.<sup><xref ref-type="bibr" rid="ref6">6</xref>,<xref ref-type="bibr" rid="ref7">7</xref></sup> A
survey of the literature shows that many approaches to cyclopenta[<italic>c</italic>]pyridines<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> and pyrazolo[3,4-<italic>b</italic>]pyridines<sup><xref ref-type="bibr" rid="ref9">9</xref></sup> have been developed,
and there are a few reports of the combination of both above bioactive
motifs into one compound.<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> Hence, an exploration
of a direct access to cyclopenta[<italic>d</italic>]pyrazolo[3,4-<italic>b</italic>]pyridines would be highly valuable for the discovery of
new bioactive compounds.</p><fig id="fig1" position="float"><label>Figure 1</label><caption><p>Some bioactive cyclopenta[<italic>c</italic>]pyridine alkaloids.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jo-2014-02096t_0002" id="gr8" position="float"/></fig><p>Multicomponent reactions (MCRs) have emerged as effective
methods
for the assembly of complex cyclic structures by the combination of
two or more distinct reactions into a one-pot transformation.<sup><xref ref-type="bibr" rid="ref11">11</xref>,<xref ref-type="bibr" rid="ref12">12</xref></sup> Among them, a branching multicomponent bicyclization not only enhances
annulation efficiency but also features bond forming efficiency and
high levels of structural complexity and minimizes the generation
of waste.<sup><xref ref-type="bibr" rid="ref13">13</xref></sup> In recent years, enormous efforts
have been made by conducting multicomponent bicyclizations toward
the formation of various heterocycles.<sup><xref ref-type="bibr" rid="ref14">14</xref>,<xref ref-type="bibr" rid="ref15">15</xref></sup> Recently,
we have also established a new multicomponent reaction of arylglyoxals
with electron-rich pyrazol-5-amines and aromatic amines, providing
highly substituted pyrazolo[3,4-<italic>b</italic>]pyridines (Scheme <xref rid="sch1" ref-type="scheme">1</xref>).<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> When 4-hydroxy-6-methyl-2<italic>H</italic>-pyran-2-one was trapped in this reaction system, tricyclic
cyclopenta[<italic>d</italic>]pyrazolo[3,4-<italic>b</italic>]pyridines
were unexpectedly obtained through a four-component bicyclization
(Scheme <xref rid="sch1" ref-type="scheme">1</xref>). Further investigations revealed
that replacing 4-hydroxy-6-methyl-2<italic>H</italic>-pyran-2-one
with cyclohexane-1,3-diones delivered the unprecedented pyrazolo[3,4-<italic>b</italic>]pyrrolo[4,3,2-<italic>de</italic>]quinolones. In this
paper, we report our interesting observations. This work represents
special examples for the regioselective construction of tri- and tetracyclic
heterocycles containing a pyrazolo[3,4-<italic>b</italic>]pyridine
unit with the concomitant formation of two new rings and five &#x003c3;-bonds.
In addition, the spatial configuration of exocyclic double bonds has
been controlled well in the former reaction, because of the intramolecular
hydrogen bond.</p><fig id="sch1" position="float"><label>Scheme 1</label><caption><title>Synthesis of Skeletally Diverse Pyrazolo[3,4-<italic>b</italic>]pyridine
Derivatives</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jo-2014-02096t_0003" id="gr1" position="float"/></fig></sec><sec id="sec2"><title>Results and Discussion</title><p>To develop a new four-component bicyclization, we began our investigation
with condition optimization by reacting 2,2-dihydroxy-1-phenylethanone <bold>1a</bold> with 3-methyl-1-phenyl-1<italic>H</italic>-pyrazol-5-amine <bold>2a</bold>, aniline <bold>3a</bold>, and 4-hydroxy-6-methyl-2<italic>H</italic>-pyran-2-one <bold>4</bold> in DMF solvent under microwave
(MW) heating. In our previous report, the multicomponent reaction
of arylglyoxals with pyrazol-5-amines and aromatic amines promoted
by <italic>p</italic>-TsOH gave highly substituted pyrazolo[3,4-<italic>b</italic>]pyridines.<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> To continue our
efforts on this project, we assume that when 4-hydroxy-6-methyl-2<italic>H</italic>-pyran-2-one was placed into the system described above,
the reaction would proceed in another direction to form cyclopenta[<italic>d</italic>]pyrazolo[3,4-<italic>b</italic>]pyridines using appropriate
promoters, based on the fact that ring opening of 4-hydroxy-6-methyl-2<italic>H</italic>-pyran-2-one with a proper nucleophile has been well established.<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> With this notion in mind, four reactants with
an equivalent molar ratio were treated with common promoters that
have been widely used in heterocyclic synthesis [e.g., K<sub>2</sub>CO<sub>3</sub>, <italic>p</italic>-TsOH, and CF<sub>3</sub>COOH (entries
1&#x02013;3, respectively, in Table <xref rid="tbl1" ref-type="other">1</xref>)]. Unfortunately,
the desired product <bold>5a</bold> was not observed at all in the
presence of the promoters mentioned above using DMF as a reaction
solvent. Further screening of promoters revealed that the use of HOAc
led to tricyclic product <bold>5a</bold>, albeit with a low yield
of 15% (entry 4). A higher yield of 57% was achieved when the reaction
was conducted in HOAc at an enhanced temperature of 80 &#x000b0;C. The
reaction works more efficiently in HOAc at 110 &#x000b0;C, affording
a 74% yield of <bold>5a</bold> (entry 7). Further increasing the temperature
above 110 &#x000b0;C did not show improvement and even gave diminished
chemical yields.</p><table-wrap id="tbl1" position="float"><label>Table 1</label><caption><title>Optimization for the Synthesis of <bold>5a</bold> under MW Heating</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jo-2014-02096t_0010" id="fx1" position="float"/><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="char" char="."/><col align="char" char="."/><col align="left"/></colgroup><thead><tr><th style="border:none;" align="center">entry</th><th style="border:none;" align="center">solvent</th><th style="border:none;" align="center">promoter (equiv)</th><th style="border:none;" align="center" char=".">temp (&#x000b0;C)</th><th style="border:none;" align="center" char=".">time (min)</th><th style="border:none;" align="center">yield<xref rid="t1fn1" ref-type="table-fn">a</xref> (%)</th></tr></thead><tbody><tr><td style="border:none;" align="left">1</td><td style="border:none;" align="left">DMF</td><td style="border:none;" align="left">K<sub>2</sub>CO<sub>3</sub> (1.0)</td><td style="border:none;" align="char" char=".">80</td><td style="border:none;" align="char" char=".">25</td><td style="border:none;" align="left">trace</td></tr><tr><td style="border:none;" align="left">2</td><td style="border:none;" align="left">DMF</td><td style="border:none;" align="left"><italic>p</italic>-TsOH (1.0)</td><td style="border:none;" align="char" char=".">80</td><td style="border:none;" align="char" char=".">25</td><td style="border:none;" align="left">trace</td></tr><tr><td style="border:none;" align="left">3</td><td style="border:none;" align="left">DMF</td><td style="border:none;" align="left">CF<sub>3</sub>CO<sub>2</sub>H (1.0)</td><td style="border:none;" align="char" char=".">80</td><td style="border:none;" align="char" char=".">25</td><td style="border:none;" align="left">trace</td></tr><tr><td style="border:none;" align="left">4</td><td style="border:none;" align="left">DMF</td><td style="border:none;" align="left">HOAc (1.0)</td><td style="border:none;" align="char" char=".">80</td><td style="border:none;" align="char" char=".">25</td><td style="border:none;" align="left">15</td></tr><tr><td style="border:none;" align="left">5</td><td style="border:none;" align="left">DMF</td><td style="border:none;" align="left">HOAc (4.0)</td><td style="border:none;" align="char" char=".">80</td><td style="border:none;" align="char" char=".">25</td><td style="border:none;" align="left">39</td></tr><tr><td style="border:none;" align="left">6</td><td style="border:none;" align="left">HOAc</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="char" char=".">80</td><td style="border:none;" align="char" char=".">25</td><td style="border:none;" align="left">57</td></tr><tr><td style="border:none;" align="left">7</td><td style="border:none;" align="left">HOAc</td><td style="border:none;" align="left">&#x02013;</td><td style="border:none;" align="char" char=".">110</td><td style="border:none;" align="char" char=".">25</td><td style="border:none;" align="left">74</td></tr></tbody></table><table-wrap-foot><fn id="t1fn1"><label>a</label><p>Isolated yield.</p></fn></table-wrap-foot></table-wrap><fig id="sch2" position="float"><label>Scheme 2</label><caption><title>Four-Component Bicyclization for Cyclopenta[<italic>d</italic>]pyrazolo[3,4-<italic>b</italic>]pyridines</title><p id="s2fn1">Reaction conditions: <bold>1</bold> (1.0 mmol), <bold>2</bold> (1.0
mmol), <bold>3</bold> (1.0 mmol), <bold>4</bold> (1.0 mmol), acetic
acid (1.5 mL), 110 &#x000b0;C, MW. Isolated
yields based on substrate <bold>2</bold>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jo-2014-02096t_0004" id="gr2" position="float"/></fig><fig id="sch3" position="float"><label>Scheme 3</label><caption><title>Domino
Synthesis of Cyclopenta[<italic>d</italic>]pyrazolo[3,4-<italic>b</italic>]pyridines</title><p id="s3fn1">Reaction conditions: <bold>1</bold> (1.0 mmol), <bold>2</bold> (2.0 mmol), <bold>4</bold> (1.0 mmol),
acetic acid (1.5 mL), 110 &#x000b0;C, MW. Isolated yields based on substrate <bold>2</bold>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jo-2014-02096t_0005" id="gr3" position="float"/></fig><p>Once the feasibility of the proposed
pathway had been validated,
we examined its scope generality by using various readily available
arylglyoxals, pyrazol-5-amines, and aromatic amines through a new
four-component bicyclization reaction. The experimental results are
presented in Scheme <xref rid="sch2" ref-type="scheme">2</xref> and showed that a broad
spectrum of substituted arylglyoxals bearing both electron-donating
and electron-withdrawing groups were successfully transformed into
the corresponding tricyclic products <bold>5a&#x02013;n</bold> in good
to excellent yields. Notably, halogen-containing arylglyoxals could
be utilized and tolerated well under the optimal reaction conditions,
furnishing the desired products in good yields, which offer possibilities
for further functionalizations by modern coupling. The variation of
nitrogen-tethered substituents on the pyrazole ring, including methyl
or phenyl groups, worked well. After successful utilization of different
substituents of arylglyoxals and pyrazol-5-amines, we next extended
our study to a variety of arylamines with different functional groups
such as chloro, methyl, and nitro on the phenyl ring. These functional
groups are compatible in the system presented here, providing the
desired products in 55&#x02013;84% yields. Even for a challenging case
in which a strong electron-withdrawing effect exists on the ortho
position on the aromatic ring (<bold>5e</bold>), a good yield of 55%
was obtained. Alternatively, instead of arylamines, this bicyclization
reaction of <bold>1</bold> with <bold>2</bold> and <bold>4</bold> in
a 1:2:1 molar ratio could also proceed, leading to the corresponding
tricyclic cyclopenta-fused pyrazolo[3,4-<italic>b</italic>]pyridines <bold>5o&#x02013;t</bold> in 61&#x02013;82% yields. Interestingly, this protocol
provides an unusual pathway for the construction of multifunctionalized
tricyclic cyclopenta-fused pyrazolo[3,4-<italic>b</italic>]pyridines
that are challenging to obtain through other methods (Schemes <xref rid="sch2" ref-type="scheme">2</xref> and <xref rid="sch3" ref-type="scheme">3</xref>).</p><p>After successfully
synthesizing cyclopenta-fused pyrazolo[3,4-<italic>b</italic>]pyridines <bold>5</bold>, we attempted to further probe
the reaction scope using dimedone (5,5-dimethylcyclohexane-1,3-dione)
(<bold>6a</bold>) to replace 4-hydroxy-6-methyl-2<italic>H</italic>-pyran-2-one <bold>4</bold> (Scheme <xref rid="sch4" ref-type="scheme">4</xref>). The
reaction of <bold>1&#x02013;3</bold> and <bold>6</bold> proceeded in
another direction to form the unprecedented pyrazolo[3,4-<italic>b</italic>]pyrrolo[4,3,2-<italic>de</italic>]quinolones. Encouraged by the
interesting results, we screened different Br&#x000f8;nsted acid promoters
to optimize the reaction conditions for this protocol. The reaction
of 2,2-dihydroxy-1-(<italic>p</italic>-tolyl)ethanone (<bold>1e</bold>), <bold>2a</bold>, <bold>3a</bold>, and <bold>6a</bold> in HOAc
at 110 &#x000b0;C gave product <bold>7a</bold> in 25% yield. After optimization,
we were pleased to find the use of 1.0 equiv of <italic>p</italic>-TsOH in DMF at 120 &#x000b0;C pushed this reaction forward, affording
a 56% chemical yield of product <bold>7a</bold>. An additional 1.0
equiv of CF<sub>3</sub>SO<sub>3</sub>H and CF<sub>3</sub>CO<sub>2</sub>H in DMF showed poor catalytic activity and almost did not promote
this reaction. Using 1.0 equiv of <italic>p</italic>-TsOH as a promoter
and DMF as a solvent, a set of diverse substituted arylglyoxals, with
groups such as methyl, methoxy, chloro, and bromo groups, were well
incorporated into these current bicyclization reactions. Arylamines
containing either electron-withdrawing or -donating substituents did
not hamper the reaction process, allowing a bicyclization strategy
to structurally complex pyrazolo[3,4-<italic>b</italic>]pyrrolo[4,3,2-<italic>de</italic>]quinolones in moderate yields. Similarly, cyclohexane-1,3-dione
can also take part in this domino bicyclization (<bold>7p</bold> and <bold>7q</bold>). Moreover, it allows one-pot access to important tetracyclic
products and gives a new bicyclization tool in an atom-efficient fashion,
providing a valuable strategy for drug discovery.</p><fig id="sch4" position="float"><label>Scheme 4</label><caption><title>Expanding the Scope
of the Bicyclization Reaction</title><p id="s4fn1">Reaction conditions: <bold>1</bold> (1.0 mmol), <bold>2</bold> (1.0 mmol), <bold>3</bold> (1.0
mmol), <bold>6</bold> (1.0 mmol), <italic>p</italic>-TsOH (1.0 mmol),
DMF (1.5
mL), 120 &#x000b0;C, MW. Isolated yields based on substrate <bold>2</bold>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jo-2014-02096t_0006" id="gr4" position="float"/></fig><p>In all cases, the complexity of the products
illustrates the remarkable
chemo- and stereoselectivity of the reaction sequence starting from
simple and common reactants. The structural elucidation and attribution
of relative stereochemistry were unambiguously determined by X-ray
diffraction analysis of single crystals of <bold>5a</bold>, <bold>5o</bold>, and <bold>7d</bold> (see the <xref rid="notes-1" ref-type="notes">Supporting
Information</xref>) and other analysis. As shown in Schemes <xref rid="sch2" ref-type="scheme">2</xref>&#x02013;<xref rid="sch4" ref-type="scheme">4</xref>, the present four-component
reaction can occur at fast speeds and can reach completion within
40 min. Water is nearly a sole byproduct, which makes workup convenient.
As mentioned previously, these heterocyclic motifs are widely prevalent
in bioactive molecules and pharmaceutical targets.</p><fig id="sch5" position="float"><label>Scheme 5</label><caption><title>Control Experiments</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jo-2014-02096t_0007" id="gr5" position="float"/></fig><p>To understand the mechanistic
hypothesis, a preformed 6-methyl-1-phenylpyridine-2,4(1<italic>H</italic>,3<italic>H</italic>)-dione <bold>8</bold>,<sup><xref ref-type="bibr" rid="ref18">18</xref></sup> derived from 4-hydroxy-6-methyl-2<italic>H</italic>-pyran-2-one
and aniline, was reacted with <bold>1c</bold> and <bold>2a</bold> under
the standard conditions. The corresponding tricyclic
product <bold>5f</bold> was obtained in 75% yield (Scheme <xref rid="sch5" ref-type="scheme">5</xref>, eq 1). Treatment with preformed pyrazolo[3,4-<italic>b</italic>]quinolones <bold>9</bold>(<xref ref-type="bibr" rid="ref19">19</xref>) and aniline <bold>3a</bold> generated a trace amount of pyrazolo[3,4-<italic>b</italic>]pyrrolo[4,3,2-<italic>de</italic>]quinolones <bold>7d</bold> (Scheme <xref rid="sch5" ref-type="scheme">5</xref>, eq 2). When the reaction of 5,5-dimethyl-3-(phenylamino)cyclohex-2-enone <bold>10</bold> with <bold>1c</bold> and <bold>2a</bold> was conducted,
a 53% yield of <bold>7d</bold> was isolated (Scheme <xref rid="sch5" ref-type="scheme">5</xref>, eq 3). These observations suggested that 4-hydroxy-6-methyl-2<italic>H</italic>-pyran-2-one and cyclohexane-1,3-diones may be, prior to
reacting with arylamines, producing intermediates <bold>8</bold> and <bold>10</bold>, which were further converted into the corresponding products <bold>5</bold> and <bold>7</bold>, respectively.</p><p>On the basis of
the experimental results, we proposed mechanisms
to explain the structural formation of multifunctionalized pyrazolo[3,4-<italic>b</italic>]pyridines <bold>5</bold> and <bold>7</bold> (Schemes <xref rid="sch6" ref-type="scheme">6</xref> and <xref rid="sch7" ref-type="scheme">7</xref>). In the former, 4-hydroxy-6-methyl-2<italic>H</italic>-pyran-2-one <bold>4</bold> initially reacted with aryl
amines <bold>3</bold> to give intermediate <bold>8</bold>, which undergoes
Knoevengel condensation with arylglyoxals <bold>1</bold> to give adducts <bold>A</bold>, followed by Michael addition and tautomerization to form
intermediate <bold>B</bold>. Next, intramolecular cyclization occurs
to afford fused pyrazolo[3,4-<italic>b</italic>]pyridines <bold>C</bold>. Subsequent ring opening of the pyridine skeleton and cycloisomerization
yield final tricyclic cyclopenta-fused pyrazolo[3,4-<italic>b</italic>]pyridines <bold>5</bold>. Similar to the former, the latter is subjected
to a sequential enamine formation/Knoevengel condensation/Michael
addition/double cyclization sequence, resulting in tetracyclic pyrazolo[3,4-<italic>b</italic>]pyrrolo[4,3,2-<italic>de</italic>]quinolones <bold>7</bold> (Scheme <xref rid="sch7" ref-type="scheme">7</xref>).</p><fig id="sch6" position="float"><label>Scheme 6</label><caption><title>Proposed Mechanism
for the Synthesis of <bold>5</bold></title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jo-2014-02096t_0008" id="gr6" position="float"/></fig><fig id="sch7" position="float"><label>Scheme 7</label><caption><title>Proposed Mechanism for the Synthesis of <bold>7</bold></title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jo-2014-02096t_0009" id="gr7" position="float"/></fig><p>In conclusion, we have successfully
established a new, flexible,
and practical four-component bicyclization reaction for the construction
of multicyclic pyrazolo[3,4-<italic>b</italic>]pyridines with good
to excellent yields using low-cost and readily accessible arylglyoxals,
pyrazol-5-amines, aromatic amines, and 4-hydroxy-6-methyl-2<italic>H</italic>-pyran-2-one (and cyclohexane-1,3-diones). Two straightforward
and operationally simple methods involve complex cascades of sequences
consisting of a Knoevengel condensation, Michael addition, and double
cyclization and allow selective access to skeletally diverse multicyclic
pyrazolo[3,4-<italic>b</italic>]pyridines by varying reaction substrates.
The characteristics of reliable scalability, flexibility of structural
modification, and wide substrate scope make this bicyclization strategy
a powerful tool for the creation of multiheterocyclic scaffolds of
general chemical and biomedical interest. We believe this methodology
may be of value to others seeking original synthetic fragments with
unique activities for medicinal and pharmaceutical studies.</p></sec><sec id="sec3"><title>Experimental Section</title><sec id="sec3.1"><title>General</title><p>Microwave
irradiation was conducted with Initiator
2.5 Microwave Synthesizers from Biotage (Uppsala, Sweden). The reaction
temperatures were measured with an infrared detector during MW heating.</p></sec><sec id="sec3.2"><title>General Procedure for the Synthesis of <bold>5</bold></title><sec id="sec3.2.1"><title>Example of
the Synthesis of <bold>5a</bold></title><p>3-Methyl-1-phenyl-1<italic>H</italic>-pyrazol-5-amine (<bold>2a</bold>, 1.0 mmol, 173 mg) was
introduced into a 10 mL Initiator reaction vial, and 2,2-dihydroxy-1-phenylethanone
(<bold>1a</bold>, 1.0 mmol, 152 mg), aniline (<bold>3a</bold>, 93
mg), and 4-hydroxy-6-methyl-2<italic>H</italic>-pyran-2-one (<bold>4</bold>, 1.0 mmol, 126 mg) as well as acetic acid (1.5 mL) were
then successively added. Subsequently, the reaction vial was capped,
and then the contents were prestirred for 20 s. The mixture was irradiated
(time, 28 min; temperature, 110 &#x000b0;C; absorption level, high; fixed
hold time) until TLC [4/1 (v/v) petroleum ether/acetone] revealed
that conversion of the starting material <bold>2a</bold> was complete.
The system was diluted with cold water (20 mL). The solid product
was collected by B&#x000fc;chner filtration and purified by flash column
chromatography (silica gel, petroleum ether/ethyl acetate mixtures)
to afford the pure product <bold>5a</bold>.</p><sec id="sec3.2.1.1"><title>(<italic>Z</italic>)-5-Hydroxy-1-methyl-3,8-diphenyl-7-[1-(phenylamino)ethylidene]-7,8-dihydrocyclopenta[<italic>d</italic>]pyrazolo[3,4-<italic>b</italic>]pyridin-6(3<italic>H</italic>)-one (<bold>5a</bold>)</title><p>Yellow solid (349 mg, 74% yield):
mp 264&#x02013;266 &#x000b0;C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) &#x003b4; 11.73 (s, 1H), 10.54 (s, 1H), 8.14 (d, <italic>J</italic> = 8.0 Hz, 2H), 7.46 (d, <italic>J</italic> = 7.6 Hz, 2H), 7.37&#x02013;7.27
(m, 6H), 7.26&#x02013;7.20 (m, 3H), 7.09 (d, <italic>J</italic> = 7.2
Hz, 2H), 5.15 (s, 1H), 2.16 (s, 3H), 1.98 (s, 3H); <sup>13</sup>C
NMR (100 MHz, CDCl<sub>3</sub>) &#x003b4; 189.8, 161.3, 157.6, 156.9,
151.6, 147.0, 143.5, 142.9, 140.0, 139.0, 137.8, 129.3, 129.1, 129.0,
128.8, 127.5, 126.1, 126.0, 124.9, 121.6, 111.5, 49.9, 17.2, 15.4;
IR (KBr, &#x003bd;) 3443, 1624, 1591, 1511, 1414, 1318, 1229, 1026,
766 cm<sup>&#x02013;1</sup>; HRMS (ESI-TOF) <italic>m</italic>/<italic>z</italic> calcd for [M &#x02013; H]<sup>&#x02212;</sup> C<sub>30</sub>H<sub>24</sub>N<sub>4</sub>O<sub>2</sub> 471.1829, found 471.1836.</p></sec><sec id="sec3.2.1.2"><title>(<italic>Z</italic>)-7-{1-[(3-Chlorophenyl)amino]ethylidene}-5-hydroxy-1-methyl-3,8-diphenyl-7,8-dihydrocyclopenta[<italic>d</italic>]pyrazolo[3,4-<italic>b</italic>]pyridin-6(3<italic>H</italic>)-one (<bold>5b</bold>)</title><p>Yellow solid (385 mg, 76% yield):
mp 276&#x02013;278 &#x000b0;C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) &#x003b4; 11.71 (s, 1H), 8.13 (d, <italic>J</italic> = 8.0 Hz, 2H),
7.47 (t, <italic>J</italic> = 7.6 Hz, 2H), 7.34&#x02013;7.27 (m, 5H),
7.19&#x02013;7.17 (m, 3H), 7.09 (s, 1H), 6.97 (d, <italic>J</italic> = 8.0 Hz, 1H), 5.13 (s, 1H), 2.15 (s, 3H), 1.99 (s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) &#x003b4; 190.3, 165.3, 161.2, 158.0,
156.6, 151.5, 143.6, 139.7, 139.2, 138.9, 134.9, 130.3, 129.0, 128.9,
127.6, 126.1, 125.9, 124.6, 122.7, 121.6, 115.9, 112.3, 109.4, 49.8,
17.2, 15.4; IR (KBr, &#x003bd;) 3413, 1699, 1632, 1618, 1509, 1437,
1388, 1306, 1251, 813, 735 cm<sup>&#x02013;1</sup>; HRMS (ESI-TOF) <italic>m</italic>/<italic>z</italic> calcd for [M &#x02013; H]<sup>&#x02212;</sup> C<sub>30</sub>H<sub>22</sub>ClN<sub>4</sub>O<sub>2</sub> 505.1440,
found 505.1453.</p></sec><sec id="sec3.2.1.3"><title>(<italic>Z</italic>)-5-Hydroxy-8-(4-methoxyphenyl)-1-methyl-3-phenyl-7-[1-(phenylamino)ethylidene]-7,8-dihydrocyclopenta[<italic>d</italic>]pyrazolo[3,4-<italic>b</italic>]pyridin-6(3<italic>H</italic>)-one (<bold>5c</bold>)</title><p>Yellow solid (366 mg, 73% yield):
mp 276&#x02013;278 &#x000b0;C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) &#x003b4; 11.70 (s, 1H), 8.15 (d, <italic>J</italic> = 7.6 Hz, 2H),
7.46 (t, <italic>J</italic> = 7.9 Hz, 2H), 7.35 (t, <italic>J</italic> = 7.6 Hz, 2H), 7.28&#x02013;7.20 (m, 2H), 7.15&#x02013;7.03 (m, 4H),
6.82 (d, <italic>J</italic> = 8.8 Hz, 2H), 5.08 (s, 1H), 3.78 (s,
3H), 2.18 (s, 3H), 1.96 (s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) &#x003b4; 189.7, 161.2, 158.8, 158.1, 157.6, 151.5, 143.6,
139.1, 137.9, 131.8, 130.0, 129.3, 129.0, 126.0, 125.9, 124.8, 121.5,
115.9, 114.1, 111.6, 109.4, 55.3, 49.1, 17.1, 15.4; IR (KBr, &#x003bd;)
3420, 1617, 1595, 1574, 1511, 1304, 814, 756 cm<sup>&#x02013;1</sup>; HRMS (ESI-TOF) <italic>m</italic>/<italic>z</italic> calcd for
[M &#x02013; H]<sup>&#x02212;</sup> C<sub>31</sub>H<sub>25</sub>N<sub>4</sub>O<sub>3</sub> 501.1935, found 501.1945.</p></sec><sec id="sec3.2.1.4"><title>(<italic>Z</italic>)-7-{1-[(3-Chlorophenyl)amino]ethylidene}-5-hydroxy-8-(4-methoxyphenyl)-1-methyl-3-phenyl-7,8-dihydrocyclopenta[<italic>d</italic>]pyrazolo[3,4-<italic>b</italic>]pyridin-6(3<italic>H</italic>)-one (<bold>5d</bold>)</title><p>Yellow solid (354 mg, 66% yield):
mp 275&#x02013;277 &#x000b0;C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) &#x003b4; 11.66 (s, 1H), 10.53 (s, 1H), 8.17&#x02013;8.10 (m, 2H),
7.47 (t, <italic>J</italic> = 6.8 Hz, 2H), 7.32 (d, <italic>J</italic> = 8.0 Hz, 2H), 7.27 (s, 1H), 7.10 (d, <italic>J</italic> = 8.0 Hz,
2H), 7.02 (d, <italic>J</italic> = 8.4 Hz, 2H), 6.83 (d, <italic>J</italic> = 7.6 Hz, 2H), 5.11 (s, 1H), 3.79 (s, 3H), 2.19 (s, 3H), 1.96 (s,
3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) &#x003b4; 189.2,
163.1, 160.2, 157.8, 155.5, 142.6, 138.5, 137.9, 130.5, 129.5, 129.4,
129.0, 128.0, 125.0, 120.5, 119.1, 119.0, 113.1, 111.6, 111.4, 111.3,
110.7, 110.5, 54.3, 48.0, 16.2, 14.4; IR (KBr, &#x003bd;) 3413, 1599,
1654, 1618, 1558, 1173, 926, 778, 642 cm<sup>&#x02013;1</sup>; HRMS
(ESI-TOF) <italic>m</italic>/<italic>z</italic> calcd for [M &#x02013;
H]<sup>&#x02212;</sup> C<sub>31</sub>H<sub>24</sub>ClN<sub>4</sub>O<sub>3</sub> 535.1545, found 535.1566.</p></sec><sec id="sec3.2.1.5"><title>(<italic>Z</italic>)-5-Hydroxy-8-(4-methoxyphenyl)-1-methyl-7-{1-[(2-nitrophenyl)amino]ethylidene}-3-phenyl-7,8-dihydrocyclopenta[<italic>d</italic>]pyrazolo[3,4-<italic>b</italic>]pyridin-6(3<italic>H</italic>)-one (<bold>5e</bold>)</title><p>Yellow solid (301 mg, 55% yield):
mp 248&#x02013;249 &#x000b0;C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) &#x003b4; 11.47 (s, 1H), 8.10 (d, <italic>J</italic> = 8.0 Hz, 2H),
7.48&#x02013;7.41 (m, 6H), 7.02 (d, <italic>J</italic> = 8.4 Hz, 2H),
6.79 (d, <italic>J</italic> = 8.0 Hz, 2H), 5.96 (s, 1H), 5.05 (s,
1H), 3.78 (s, 3H), 2.32 (s, 3H), 1.80 (s, 3H); <sup>13</sup>C NMR
(100 MHz, CDCl<sub>3</sub>) &#x003b4; 191.0, 161.2, 158.9, 158.7, 155.8,
149.2, 146.3, 143.6, 138.1, 136.8, 131.4, 129.9, 129.4, 129.0, 127.7,
126.2, 123.9, 121.7, 114.2, 113.2, 102.3, 55.3, 48.7, 18.4, 16.7,
15.4, 14.1; IR (KBr, &#x003bd;) 3416, 1621, 1589, 1567, 1510, 1498,
1254, 1080, 813, 690 cm<sup>&#x02013;1</sup>; HRMS (ESI-TOF) <italic>m</italic>/<italic>z</italic> calcd for [M &#x02013; H]<sup>&#x02212;</sup> C<sub>31</sub>H<sub>24</sub>N<sub>5</sub>O<sub>5</sub> 546.1786,
found 546.1791.</p></sec><sec id="sec3.2.1.6"><title>(<italic>Z</italic>)-8-(4-Chlorophenyl)-5-hydroxy-1-methyl-3-phenyl-7-[1-(phenylamino)ethylidene]-7,8-dihydrocyclopenta[<italic>d</italic>]pyrazolo[3,4-<italic>b</italic>]pyridin-6(3<italic>H</italic>)-one (<bold>5f</bold>)</title><p>Yellow solid (359 mg, 71% yield):
mp 256&#x02013;258 &#x000b0;C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) &#x003b4; 11.71 (s, 1H), 10.55 (s, 1H), 8.15 (d, <italic>J</italic> = 7.6 Hz, 2H), 7.47 (t, <italic>J</italic> = 7.6 Hz, 2H), 7.36 (t, <italic>J</italic> = 7.6 Hz, 2H), 7.28 (m, 3H), 7.22 (m, 1H), 7.14 (d, <italic>J</italic> = 7.6 Hz, 2H), 7.09 (d, <italic>J</italic> = 7.2 Hz, 2H),
5.11 (s, 1H), 2.19 (s, 3H), 1.95 (s, 3H); <sup>13</sup>C NMR (100
MHz, CDCl<sub>3</sub>) &#x003b4; 189.6, 161.2, 157.6, 143.2, 138.9,
138.6, 137.7, 133.3, 130.3, 129.3, 129.1, 129.0, 127.2, 126.2, 126.1,
124.9, 121.6, 117.4, 116.1, 113.2, 111.1, 49.1, 17.2, 15.5; IR (KBr,
&#x003bd;) 3421, 1619, 1588, 1566, 1489, 1438, 1242, 1079, 759, 633
cm<sup>&#x02013;1</sup>; HRMS (ESI-TOF) <italic>m</italic>/<italic>z</italic> calcd for [M &#x02013; H]<sup>&#x02212;</sup> C<sub>30</sub>H<sub>22</sub>ClN<sub>4</sub>O<sub>2</sub> 505.1440, found 505.1445.</p></sec><sec id="sec3.2.1.7"><title>(<italic>Z</italic>)-8-(4-Bromophenyl)-5-hydroxy-1-methyl-3-phenyl-7-[1-(<italic>p</italic>-tolylamino)ethylidene]-7,8-dihydrocyclopenta[<italic>d</italic>]pyrazolo[3,4-<italic>b</italic>]pyridin-6(3<italic>H</italic>)-one
(<bold>5g</bold>)</title><p>Yellow solid (474 mg, 84% yield): mp 288&#x02013;290
&#x000b0;C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) &#x003b4; 11.65
(s, 1H), 10.62 (s, 1H), 8.15 (d, <italic>J</italic> = 7.6 Hz, 2H),
7.49&#x02013;7.43 (m, <italic>J</italic> = 8.0 Hz, 4H), 7.29 (s, 1H),
7.16 (d, <italic>J</italic> = 7.6 Hz, 2H), 7.08 (d, <italic>J</italic> = 8.0 Hz, 2H), 6.98 (d, <italic>J</italic> = 7.2 Hz, 2H), 5.11 (s,
1H), 2.35 (s, 3H<sub>3</sub>), 2.20 (s, 3H), 1.93 (s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) &#x003b4; 189.4, 161.2, 158.1, 156.9,
143.1, 139.3, 139.0, 136.3, 135.5, 135.0, 132.0, 130.6, 129.9, 129.0,
126.1, 125.0, 121.6, 121.3, 110.7, 58.4, 49.2, 21.0, 18.4, 17.1, 15.5;
IR (KBr, &#x003bd;) 3214, 1625, 1592, 1566, 1487, 1319, 1079, 809, 689
cm<sup>&#x02013;1</sup>; HRMS (ESI-TOF) <italic>m</italic>/<italic>z</italic> calcd for [M &#x02013; H]<sup>&#x02212;</sup> C<sub>31</sub>H<sub>24</sub>BrN<sub>4</sub>O<sub>2</sub> 563.1091, found 563.1092.</p></sec><sec id="sec3.2.1.8"><title>(<italic>Z</italic>)-7-{1-[(4-Chlorophenyl)amino]ethylidene}-5-hydroxy-1,3-dimethyl-8-phenyl-7,8-dihydrocyclopenta[<italic>d</italic>]pyrazolo[3,4-<italic>b</italic>]pyridin-6(3<italic>H</italic>)-one (<bold>5h</bold>)</title><p>Yellow solid (280 mg, 63% yield):
mp 278&#x02013;280 &#x000b0;C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) &#x003b4; 11.63 (s, 1H), 7.34&#x02013;7.27 (m, 3H), 7.27&#x02013;7.21
(m, 2H), 7.16 (d, <italic>J</italic> = 7.2 Hz, 2H), 7.00 (d, <italic>J</italic> = 7.6 Hz, 2H), 5.07 (s, 1H), 3.95 (s, 3H), 2.07 (s, 3H),
1.94 (s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) &#x003b4;
191.1, 161.2, 155.6, 147.6, 142.0, 138.4, 137.1, 133.4, 133.0, 130.1,
129.2, 129.1, 112.5, 99.9, 48.6, 34.9, 34.2, 30.9, 16.7, 15.2, 13.9;
IR (KBr, &#x003bd;) 3418, 1668, 1606, 1566, 1496, 1237, 800, 702, 601
cm<sup>&#x02013;1</sup>; HRMS (ESI-TOF) <italic>m</italic>/<italic>z</italic> calcd for [M &#x02013; H]<sup>&#x02212;</sup> C<sub>25</sub>H<sub>20</sub>ClN<sub>4</sub>O<sub>2</sub> 443.1283, found 443.1315.</p></sec><sec id="sec3.2.1.9"><title>(<italic>Z</italic>)-5-Hydroxy-8-(4-methoxyphenyl)-1,3-dimethyl-7-[1-(<italic>p</italic>-tolylamino)ethylidene]-7,8-dihydrocyclopenta[<italic>d</italic>]pyrazolo[3,4-<italic>b</italic>]pyridin-6(3<italic>H</italic>)-one
(<bold>5i</bold>)</title><p>Yellow solid (277 mg, 61% yield): mp 235&#x02013;237
&#x000b0;C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) &#x003b4; 11.58
(s, 1H), 7.14 (d, <italic>J</italic> = 8.0 Hz, 2H), 7.07 (d, <italic>J</italic> = 8.4 Hz, 2H), 6.96 (d, <italic>J</italic> = 8.0 Hz, 2H),
6.80 (d, <italic>J</italic> = 8.8 Hz, 2H), 5.04 (s, 1H), 3.95 (s,
3H), 3.77 (s, 3H), 2.34 (s, 3H), 2.10 (s, 3H), 1.93 (s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) &#x003b4; 189.8, 161.3, 158.7,
157.7, 157.5, 141.8, 135.9, 135.3, 132.0, 130.0, 129.8, 124.9, 124.8,
116.7, 114.0, 111.2, 55.3, 49.0, 30.0, 21.0, 17.0, 15.3; IR (KBr,
&#x003bd;) 3414, 1625, 1589, 1567, 1438, 1324, 1017, 827, 654 cm<sup>&#x02013;1</sup>; HRMS (ESI-TOF) <italic>m</italic>/<italic>z</italic> calcd for [M &#x02013; H]<sup>&#x02212;</sup> C<sub>27</sub>H<sub>25</sub>N<sub>4</sub>O<sub>3</sub> 453.1935, found 453.1964.</p></sec><sec id="sec3.2.1.10"><title>(<italic>Z</italic>)-7-{1-[(4-Chlorophenyl)amino]ethylidene}-5-hydroxy-8-(4-methoxyphenyl)-1,3-dimethyl-7,8-dihydrocyclopenta[<italic>d</italic>]pyrazolo[3,4-<italic>b</italic>]pyridin-6(3<italic>H</italic>)-one (<bold>5j</bold>)</title><p>Yellow solid (313 mg, 66% yield):
mp 250&#x02013;252 &#x000b0;C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) &#x003b4; 11.61 (s, 1H), 7.30 (d, <italic>J</italic> = 7.6 Hz, 2H),
7.06 (d, <italic>J</italic> = 7.2 Hz, 2H), 7.01 (d, <italic>J</italic> = 7.2 Hz, 2H), 6.81 (d, <italic>J</italic> = 7.6 Hz, 2H), 5.03 (s,
1H), 3.95 (s, 3H), 3.78 (s, 3H), 2.10 (s, 3H), 1.94 (s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) &#x003b4; 189.6, 161.2, 157.6,
141.5, 138.8, 136.1, 135.1, 133.1, 130.2, 129.8, 128.9, 124.9, 110.7,
107.3, 58.4, 49.0, 34.0, 31.0, 21.0, 18.4, 17.1, 15.3; IR (KBr, &#x003bd;)
3419, 1616, 1593, 1562, 1432, 1302, 1089, 808, 689 cm<sup>&#x02013;1</sup>; HRMS (ESI-TOF) <italic>m</italic>/<italic>z</italic> calcd for
[M &#x02013; H]<sup>&#x02212;</sup> C<sub>26</sub>H<sub>22</sub>ClN<sub>4</sub>O<sub>3</sub> 473.1389, found 473.1420.</p></sec><sec id="sec3.2.1.11"><title>(<italic>Z</italic>)-8-(4-Chlorophenyl)-7-{1-[(4-chlorophenyl)amino]ethylidene}-5-hydroxy-1,3-dimethyl-7,8-dihydrocyclopenta[<italic>d</italic>]pyrazolo[3,4-<italic>b</italic>]pyridin-6(3<italic>H</italic>)-one (<bold>5k</bold>)</title><p>Yellow solid (339 mg, 71% yield):
mp 269&#x02013;270 &#x000b0;C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) &#x003b4; 11.65 (s, 1H), 7.33 (d, <italic>J</italic> = 8.4 Hz, 2H),
7.28 (d, <italic>J</italic> = 8.4 Hz, 2H), 7.12 (d, <italic>J</italic> = 8.4 Hz, 2H), 7.02 (d, <italic>J</italic> = 8.4 Hz, 2H), 5.07 (s,
1H), 3.98 (s, 3H), 2.13 (s, 3H), 1.95 (s, 3H); <sup>13</sup>C NMR
(100 MHz, CDCl<sub>3</sub>) &#x003b4; 190.2, 161.2, 156.4, 141.7, 138.6,
136.5, 133.3, 131.6, 130.2, 129.4, 129.0, 126.0, 111.6, 48.9, 34.1,
17.1, 15.3; IR (KBr, &#x003bd;) 3416, 1663, 1616, 1582, 1499, 1314,
1011, 726 cm<sup>&#x02013;1</sup>; HRMS (ESI-TOF) <italic>m</italic>/<italic>z</italic> calcd for [M &#x02013; H]<sup>&#x02212;</sup> C<sub>25</sub>H<sub>19</sub>Cl<sub>2</sub>N<sub>4</sub>O<sub>2</sub> 477.0893,
found 477.0891.</p></sec><sec id="sec3.2.1.12"><title>(<italic>Z</italic>)-7-{1-[(4-Chlorophenyl)amino]ethylidene}-1-cyclopropyl-5-hydroxy-8-(4-methoxyphenyl)-3-methyl-7,8-dihydrocyclopenta[<italic>d</italic>]pyrazolo[3,4-<italic>b</italic>]pyridin-6(3<italic>H</italic>)-one (<bold>5l</bold>)</title><p>Yellow solid (320 mg, 64% yield):
mp 276&#x02013;278 &#x000b0;C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) &#x003b4; 11.62 (s, 1H), 10.66 (s, 1H), 7.30 (d, <italic>J</italic> = 8.0 Hz, 2H), 7.07 (d, <italic>J</italic> = 8.0 Hz, 2H), 7.01 (d, <italic>J</italic> = 8.0 Hz, 2H), 6.79 (d, <italic>J</italic> = 8.0 Hz, 2H),
5.13 (s, 1H), 3.92 (s, 3H), 3.77 (s, 3H), 1.96 (s, 3H), 1.79&#x02013;1.46
(m, 1H), 0.90&#x02013;0.84 (m, 2H), 0.71 (s, 1H), 0.55 (s, 1H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) &#x003b4; 190.4, 161.2, 158.7,
157.2, 156.2, 147.0, 141.9, 139.4, 136.7, 131.9, 131.2, 129.8, 129.4,
125.9, 125.8, 114.1, 112.2, 55.3, 49.1, 34.1, 17.1, 9.7, 7.3, 7.2;
IR (KBr, &#x003bd;) 3419, 1682, 1609, 1588, 1562, 1496, 1256, 1055,
775 cm<sup>&#x02013;1</sup>; HRMS (ESI-TOF) <italic>m</italic>/<italic>z</italic> calcd for [M &#x02013; H]<sup>&#x02212;</sup> C<sub>28</sub>H<sub>24</sub>ClN<sub>4</sub>O<sub>3</sub> 499.1545, found 499.1549.</p></sec><sec id="sec3.2.1.13"><title>(<italic>Z</italic>)-8-(4-Chlorophenyl)-1-cyclopropyl-5-hydroxy-3-methyl-7-[1-(<italic>p</italic>-tolylamino)ethylidene]-7,8-dihydrocyclopenta[<italic>d</italic>]pyrazolo[3,4-<italic>b</italic>]pyridin-6(3<italic>H</italic>)-one
(<bold>5m</bold>)</title><p>Yellow solid (324 mg, 67% yield): mp 252&#x02013;253
&#x000b0;C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) &#x003b4; 11.60
(s, 1H), 10.67 (s, 1H), 7.24 (d, <italic>J</italic> = 6.8 Hz, 2H),
7.13 (m, 4H), 6.97 (d, <italic>J</italic> = 7.3 Hz, 2H), 5.15 (s,
1H), 3.92 (s, 3H), 2.34 (s, 3H), 1.93 (s, 3H), 1.64&#x02013;1.54 (m,
1H), 0.89 (s, 2H), 0.68 (s, 1H), 0.54 (s, 1H); <sup>13</sup>C NMR
(100 MHz, CDCl<sub>3</sub>) &#x003b4; 190.8, 161.1, 155.6, 149.3, 149.2,
147.7, 141.9, 140.2, 138.6, 136.9, 133.1, 131.8, 130.8, 130.4, 128.2,
115.9, 112.0, 100.0, 48.2, 34.9, 34.2, 16.8, 15.3, 13.9; IR (KBr,
&#x003bd;) 3293, 1613, 1598, 1564, 1516, 1488, 1264, 1015, 808, 716
cm<sup>&#x02013;1</sup>; HRMS (ESI-TOF) <italic>m</italic>/<italic>z</italic> calcd for [M &#x02013; H]<sup>&#x02212;</sup> C<sub>28</sub>H<sub>24</sub>ClN<sub>4</sub>O<sub>2</sub> 483.1596, found 483.1596.</p></sec><sec id="sec3.2.1.14"><title>(<italic>Z</italic>)-8-(4-Chlorophenyl)-7-{1-[(4-chlorophenyl)amino]ethylidene}-1-cyclopropyl-5-hydroxy-3-methyl-7,8-dihydrocyclopenta[<italic>d</italic>]pyrazolo[3,4-<italic>b</italic>]pyridin-6(3<italic>H</italic>)-one (<bold>5n</bold>)</title><p>Yellow solid (307 mg, 61% yield):
mp 234&#x02013;256 &#x000b0;C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) &#x003b4; 11.63 (s, 1H), 7.32 (d, <italic>J</italic> = 7.6 Hz, 2H),
7.25 (d, <italic>J</italic> = 7.2 Hz, 2H), 7.11 (d, <italic>J</italic> = 7.2 Hz, 2H), 7.02 (d, <italic>J</italic> = 7.6 Hz, 2H), 5.17 (s,
1H), 3.93 (s, 3H), 1.95 (s, 3H), 0.90 (s, 2H), 0.62 (m, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) &#x003b4; 190.3, 161.1, 156.3,
146.8, 138.8, 138.0, 136.5, 133.1, 131.5, 130.1, 129.4, 128.9, 126.0,
118.9, 113.2, 111.8, 49.1, 34.1, 30.9, 17.1, 9.7, 7.5, 7.0; IR (KBr,
&#x003bd;) 3137, 1682, 1608, 1590, 1562, 1497, 1213, 1054, 758, 714
cm<sup>&#x02013;1</sup>; HRMS (ESI-TOF) <italic>m</italic>/<italic>z</italic> calcd for [M &#x02013; H]<sup>&#x02212;</sup> C<sub>27</sub>H<sub>21</sub>Cl<sub>2</sub>N<sub>4</sub>O<sub>2</sub> 503.1050,
found 503.1061.</p></sec></sec><sec id="sec3.2.2"><title>Example of the Synthesis of <bold>5o</bold></title><p>3-Methyl-1-phenyl-1<italic>H</italic>-pyrazol-5-amine (<bold>2a</bold>, 2.0 mmol, 346 mg) was
introduced into a 10 mL Initiator reaction vial, and 2,2-dihydroxy-1-phenylethanone
(<bold>1a</bold>, 1.0 mmol, 152 mg) and 4-hydroxy-6-methyl-2<italic>H</italic>-pyran-2-one (<bold>4</bold>, 1.0 mmol, 126 mg) as well
as acetic acid (1.5 mL) were then successively added. Subsequently,
the reaction vial was capped, and then the contents were prestirred
for 20 s. The mixture was irradiated (time, 25 min; temperature, 110
&#x000b0;C; absorption level, high; fixed hold time) until TLC [4/1 (v/v)
petroleum ether/acetone] revealed that conversion of starting material <bold>2a</bold> was complete. The system was diluted with cold water (20
mL). The solid product was collected by B&#x000fc;chner filtration
and purified by flash column chromatography (silica gel, petroleum
ether/ethyl acetate mixtures) to afford pure product <bold>5o</bold>.</p><sec id="sec3.2.2.1"><title>(<italic>Z</italic>)-5-Hydroxy-1-methyl-7-{1-[3-methyl(1-phenyl-1<italic>H</italic>-pyrazol-5-yl)amino]ethylidene}-3,8-diphenyl-7,8-dihydrocyclopenta[<italic>d</italic>]pyrazolo[3,4-<italic>b</italic>]pyridin-6(3<italic>H</italic>)-one (<bold>5o</bold>)</title><p>Yellow solid (420 mg, 76% yield):
mp 268&#x02013;269 &#x000b0;C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) &#x003b4; 11.47 (s, 1H), 10.23 (s, 1H), 8.11 (d, <italic>J</italic> = 8.0 Hz, 2H), 7.50&#x02013;7.39 (m, 6H), 7.34&#x02013;7.31 (m, 2H),
7.26&#x02013;7.22 (m, 3H), 7.10 (d, <italic>J</italic> = 6.4 Hz, 2H),
5.96 (s, 1H), 5.06 (s, 1H), 2.31 (s, 3H), 2.13 (s, 3H), 1.77 (s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) &#x003b4; 191.1, 161.1, 158.3,
156.0, 149.2, 143.7, 139.6, 138.9, 138.0, 136.8, 129.4, 129.0, 128.9,
128.8, 127.7, 127.6, 126.2, 123.9, 121.6, 115.7, 113.1, 109.4, 102.4,
49.4, 16.8, 15.34, 14.1; IR (KBr, &#x003bd;) 3425, 1620, 1593, 1556,
1510, 1377, 1318, 1130, 725, 669 cm<sup>&#x02013;1</sup>; HRMS (ESI-TOF) <italic>m</italic>/<italic>z</italic> calcd for [M &#x02013; H]<sup>&#x02212;</sup> C<sub>34</sub>H<sub>27</sub>N<sub>6</sub>O<sub>2</sub> 551.2204,
found 551.2232.</p></sec><sec id="sec3.2.2.2"><title>(<italic>Z</italic>)-8-(4-Bromophenyl)-5-hydroxy-1-methyl-7-{1-[(3-methyl-1-phenyl-1<italic>H</italic>-pyrazol-5-yl)amino]ethylidene}-3-phenyl-7,8-dihydrocyclopenta[<italic>d</italic>]pyrazolo[3,4-<italic>b</italic>]pyridin-6(3<italic>H</italic>)-one (<bold>5p</bold>)</title><p>Yellow solid (517 mg, 82% yield):
mp 258&#x02013;260 &#x000b0;C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) &#x003b4; 11.45 (s, 1H), 10.27 (s, 1H), 8.10 (d, <italic>J</italic> = 8.0 Hz, 2H), 7.49&#x02013;7.38 (m, 8H), 7.34 (t, <italic>J</italic> = 6.8 Hz, 1H), 7.29 (d, <italic>J</italic> = 7.6 Hz, 1H), 6.97 (d, <italic>J</italic> = 8.3 Hz, 2H), 5.98 (s, 1H), 5.03 (s, 1H), 2.32 (s, 3H),
2.17 (s, 3H), 1.74 (s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) &#x003b4; 190.9, 161.1, 155.8, 149.3, 143.6, 143.4(0), 143.3(8),
138.7, 137.8, 136.7, 132.1, 132.0, 130.4, 129.5, 129.1, 127.9(4),
127.9(2), 126.3(4), 126.3(3), 124.0, 121.7, 121.4, 112.8, 102.4, 48.7,
17.0, 15.5, 14.0; IR (KBr, &#x003bd;) 3447, 1782, 1626, 1594, 1502,
1409, 1412, 1236, 1129, 1101, 758 cm<sup>&#x02013;1</sup>; HRMS (ESI-TOF) <italic>m</italic>/<italic>z</italic> calcd for [M &#x02013; H]<sup>&#x02212;</sup> C<sub>34</sub>H<sub>26</sub>BrN<sub>6</sub>O<sub>2</sub> 629.1309,
found 629.1324.</p></sec><sec id="sec3.2.2.3"><title>(<italic>Z</italic>)-8-(4-Fluorophenyl)-5-hydroxy-1-methyl-7-{1-[(3-methyl-1-phenyl-1<italic>H</italic>-pyrazol-5-yl)amino]ethylidene}-3-phenyl-7,8-dihydrocyclopenta[<italic>d</italic>]pyrazolo[3,4-<italic>b</italic>]pyridin-6(3<italic>H</italic>)-one (<bold>5q</bold>)</title><p>Yellow solid (416 mg, 73% yield):
mp 276&#x02013;279 &#x000b0;C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) &#x003b4; 11.48 (s, 1H), 10.31 (s, 1H), 8.09 (d, <italic>J</italic> = 8.0 Hz, 2H), 7.50&#x02013;7.40 (m, 6H), 7.34 (t, <italic>J</italic> = 6.8 Hz, 1H), 7.31&#x02013;7.27 (m, 1H), 7.11&#x02013;7.03 (m, 2H),
6.96 (t, <italic>J</italic> = 8.4 Hz, 2H), 5.98 (s, 1H), 5.05 (s,
1H), 2.32 (s, 3H), 2.14 (s, 3H), 1.74 (s, 3H); <sup>13</sup>C NMR
(100 MHz, CDCl<sub>3</sub>) &#x003b4; 190.9, 163.1, 159.3 (<sup>1</sup><italic>J</italic><sub>CF</sub> = 271.3), 157.9, 156.0, 149.3, 143.4,
138.8, 138.1, 136.6, 135.4 (<sup>2</sup><italic>J</italic><sub>CF</sub> = 3.3), 130.4, 130.3 (<sup>3</sup><italic>J</italic><sub>CF</sub> = 8), 129.4, 129.0, 127.7, 126.2, 123.9, 121.5, 115.9, 115.8 (<sup>4</sup><italic>J</italic><sub>CF</sub> = 21.5), 112.8, 109.2, 102.5,
48.6, 16.8, 15.4, 14.1; IR (KBr, &#x003bd;) 3464, 1621, 1591, 1576,
1379, 1329, 1225, 1156, 815, 756 cm<sup>&#x02013;1</sup>; HRMS (ESI-TOF) <italic>m</italic>/<italic>z</italic> calcd for [M &#x02013; H]<sup>&#x02212;</sup> C<sub>34</sub>H<sub>26</sub>FN<sub>6</sub>O<sub>2</sub> 569.2110,
found 569.2136.</p></sec><sec id="sec3.2.2.4"><title>(<italic>Z</italic>)-8-(4-Chlorophenyl)-7-{1-[(1,3-dimethyl-1<italic>H</italic>-pyrazol-5-yl)amino]ethylidene}-5-hydroxy-1,3-dimethyl-7,8-dihydrocyclopenta[<italic>d</italic>]pyrazolo[3,4-<italic>b</italic>]pyridin-6(3<italic>H</italic>)-one (<bold>5r</bold>)</title><p>Yellow solid (282 mg, 61% yield):
mp 158&#x02013;160 &#x000b0;C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) &#x003b4; 11.54 (s, 1H), 7.27 (d, <italic>J</italic> = 6.4 Hz, 2H),
7.11 (d, <italic>J</italic> = 7.6 Hz, 2H), 5.74 (s, 1H), 5.09 (s,
1H), 3.97 (s, 3H), 3.71 (s, 3H), 2.21 (s, 3H), 2.12 (s, 3H), 1.90
(s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) &#x003b4; 191.1,
161.1, 155.6, 149.3, 147.6, 142.0, 138.4, 137.1, 133.5, 130.0, 129.1,
117.9, 112.5, 99.8, 48.6, 34.9, 34.2, 30.9, 16.7, 15.2, 13.9; IR (KBr,
&#x003bd;) 3454, 1698, 1659, 1636, 1560, 1207, 1131, 643, 515 cm<sup>&#x02013;1</sup>; HRMS (ESI-TOF) <italic>m</italic>/<italic>z</italic> calcd for [M &#x02013; H]<sup>&#x02212;</sup> C<sub>24</sub>H<sub>22</sub>ClN<sub>6</sub>O<sub>2</sub> 461.1501, found 461.1532.</p></sec><sec id="sec3.2.2.5"><title>(<italic>Z</italic>)-8-(3,4-Dichlorophenyl)-7-{1-[(1,3-dimethyl-1<italic>H</italic>-pyrazol-5-yl)amino]ethylidene}-5-hydroxy-1,3-dimethyl-7,8-dihydrocyclopenta[<italic>d</italic>]pyrazolo[3,4-<italic>b</italic>]pyridin-6(3<italic>H</italic>)-one (<bold>5s</bold>)</title><p>Yellow solid (322 mg, 65% yield):
mp 171&#x02013;173 &#x000b0;C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) &#x003b4; 11.53 (s, 1H), 10.63 (s, 1H),7.39 (d, <italic>J</italic> = 8.4 Hz, 1H), 7.22 (d, <italic>J</italic> = 2.0 Hz, 1H), 7.08&#x02013;7.05
(m, 1H), 5.76 (s, 1H), 5.07 (s, 1H), 3.98 (s, 3H), 3.73 (s, 3H), 2.22
(s, 3H), 2.17 (s, 3H), 1.92 (s, 3H); <sup>13</sup>C NMR (100 MHz,
CDCl<sub>3</sub>) &#x003b4; 191.3, 161.2, 155.6, 147.5, 146.3, 146.1,
145.8, 145.1, 142.2, 139.7, 137.3, 128.9, 128.9, 127.6, 112.9, 99.8,
58.5, 49.4, 34.9, 34.1, 18.4, 16.6 15.1, 13.9; IR (KBr, &#x003bd;) 3444,
1690, 1620, 1561, 1423, 1339, 1176, 1032, 814 cm<sup>&#x02013;1</sup>; HRMS (ESI-TOF) <italic>m</italic>/<italic>z</italic> calcd for
[M &#x02013; H]<sup>&#x02212;</sup> C<sub>24</sub>H<sub>21</sub>Cl<sub>2</sub>N<sub>6</sub>O<sub>2</sub> 495.1111, found 495.1139.</p></sec><sec id="sec3.2.2.6"><title>(<italic>Z</italic>)-7-{1-[(1,3-Dimethyl-1<italic>H</italic>-pyrazol-5-yl)amino]ethylidene}-5-hydroxy-8-(4-methoxyphenyl)-1,3-dimethyl-7,8-dihydrocyclopenta[<italic>d</italic>]pyrazolo[3,4-<italic>b</italic>]pyridin-6(3<italic>H</italic>)-one (<bold>5t</bold>)</title><p>Yellow solid (307 mg, 67% yield):
mp 150&#x02013;152 &#x000b0;C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) &#x003b4; 11.54 (s, 1H), 10.70 (s, 1H), 7.07 (d, <italic>J</italic> = 8.0 Hz, 2H), 6.81 (d, <italic>J</italic> = 8.0 Hz, 2H), 5.73 (s,
1H), 5.06 (s, 1H), 3.97 (s, 3H), 3.78 (s, 3H), 3.72 (s, 3H), 2.21
(s, 3H), 2.11 (s, 3H), 1.91 (s, 3H); <sup>13</sup>C NMR (100 MHz,
CDCl<sub>3</sub>) &#x003b4; 191.4, 161.2, 158.9, 155.4, 147.5, 142.3,
137.4, 131.5, 129.9, 127.7, 126.6, 114.2, 113.0, 100.0, 99.8, 55.3,
48.6, 34.9, 34.1, 18.4, 16.6, 15.2, 13.9; IR (KBr, &#x003bd;) 3444,
1696, 1620, 1561, 1310, 1254, 1032, 814, 649 cm<sup>&#x02013;1</sup>; HRMS (ESI-TOF) <italic>m</italic>/<italic>z</italic> calcd for
[M &#x02013; H]<sup>&#x02212;</sup> C<sub>25</sub>H<sub>25</sub>N<sub>6</sub>O<sub>3</sub> 457.1996, found 457.2026.</p></sec></sec><sec id="sec3.2.3"><title>Example of
the Synthesis of <bold>7a</bold></title><p>5,5-Dimethylcyclohexane-1,3-dione
(<bold>6a</bold>, 1.0 mmol, 140 mg) and aniline (<bold>3a</bold>,
1.0 mmol, 93 mg) were introduced into a 10 mL Initiator reaction vial,
and 2,2-dihydroxy-1-(<italic>p</italic>-tolyl)ethanone (<bold>1e</bold>, 1.0 mmol, 166 mg), 3-methyl-1-phenyl-1<italic>H</italic>-pyrazol-5-amine
(<bold>2a</bold>, 1.0 mmol, 173 mg), and <italic>p</italic>-TsOH (1.0
mmol, 172 mg) as well as <italic>N</italic>,<italic>N</italic>-dimethylformamide
(DMF, 1.5 mL) were then successively added. Subsequently, the reaction
vial was capped, and then the contents were prestirred for 20 s. The
mixture was irradiated (time, 28 min; temperature, 120 &#x000b0;C; absorption
level, high; fixed hold time) until TLC [4/1 (v/v) petroleum ether/acetone]
revealed that conversion of starting material <bold>2a</bold> was
complete. The system was neutralized with diluted chlorhydric acid
and then diluted with cold water (40 mL). The solid product was collected
by B&#x000fc;chner filtration and purified by flash column chromatography
(silica gel, petroleum ether/ethyl acetate mixtures) to afford pure
product <bold>7a</bold>.</p><sec id="sec3.2.3.1"><title>4,4,9-Trimethyl-2,7-diphenyl-1-(<italic>p</italic>-tolyl)-3,4,5,7-tetrahydro-2<italic>H</italic>-pyrazolo[3,4-<italic>b</italic>]pyrrolo[4,3,2-<italic>de</italic>]quinolone (<bold>7a</bold>)</title><p>Yellow solid (270
mg, 56% yield): mp 269&#x02013;271 &#x000b0;C; <sup>1</sup>H NMR (400
MHz, CDCl<sub>3</sub>) &#x003b4; 8.16&#x02013;8.14 (m, 2H), 7.50&#x02013;7.46
(m, 2H), 7.34&#x02013;7.32 (m, 3H), 7.26&#x02013;7.24 (m, 1H), 7.19
(d, <italic>J</italic> = 8.0 Hz, 2H), 7.13&#x02013;7.11 (m, 2H), 7.07
(d, <italic>J</italic> = 7.6 Hz, 2H), 2.92 (s, 2H), 2.69 (s, 2H),
2.33 (s, 3H), 2.02 (s, 3H), 1.15 (s, 6H); <sup>13</sup>C NMR (100
MHz, CDCl<sub>3</sub>) &#x003b4; 159.3, 142.6, 140.0, 137.7, 137.6,
132.3, 131.7, 129.9, 128.9(2), 128.8(7), 128.8, 128.4, 128.0, 127.7,
125.8, 122.9, 122.7, 115.2, 114.2, 104.9, 45.3, 37.2, 35.5, 29.0,
21.3, 15.6; HRMS (ESI-TOF) <italic>m</italic>/<italic>z</italic> calcd
for [M + H]<sup>+</sup> C<sub>33</sub>H<sub>31</sub>N<sub>4</sub> 483.2543,
found 483.2578.</p></sec><sec id="sec3.2.3.2"><title>1-(4-Fluorophenyl)-4,4,9-trimethyl-7-phenyl-2-(<italic>p</italic>-tolyl)-3,4,5,7-tetrahydro-2<italic>H</italic>-pyrazolo[3,4-<italic>b</italic>]pyrrolo[4,3,2-<italic>de</italic>]quinoline (<bold>7b</bold>)</title><p>White solid (295 mg, 59% yield): mp 296&#x02013;297 &#x000b0;C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) &#x003b4; 8.16 (d, <italic>J</italic> = 8.0 Hz, 2H), 7.53&#x02013;7.49 (m, 2H), 7.33&#x02013;7.28
(m, 3H), 7.17 (d, <italic>J</italic> = 8.0 Hz, 2H), 7.03&#x02013;7.00
(m, 4H), 2.97 (s, 2H), 2.72 (s, 2H), 2.39 (s, 3H), 2.04 (s, 3H), 1.18
(s, 6H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) &#x003b4; 162.4
(<sup>1</sup><italic>J</italic><sub>CF</sub> = 246.2 Hz), 159.3, 142.4,
139.9, 138.2, 134.7, 134.1 (<sup>2</sup><italic>J</italic><sub>CF</sub> = 8.1 Hz), 129.6, 129.4, 129.2 (<sup>4</sup><italic>J</italic><sub>CF</sub> = 3.5 Hz), 129.0, 128.9, 127.4, 125.9, 122.9, 121.4, 115.0,
114.8 (<sup>4</sup><italic>J</italic><sub>CF</sub> = 21.3 Hz), 114.5,
104.7, 45.3, 37.1, 35.6, 29.0, 21.1, 15.6; HRMS (ESI-TOF) <italic>m</italic>/<italic>z</italic> calcd for [M + H]<sup>+</sup> C<sub>33</sub>H<sub>30</sub>FN<sub>4</sub> 501.2454, found 501.2483.</p></sec><sec id="sec3.2.3.3"><title>2-(4-Bromophenyl)-1-(4-chlorophenyl)-4,4,9-trimethyl-7-phenyl-3,4,5,7-tetrahydro-2<italic>H</italic>-pyrazolo[3,4-<italic>b</italic>]pyrrolo[4,3,2-<italic>de</italic>]quinolone (<bold>7c</bold>)</title><p>White solid (249
mg, 43% yield): mp 280&#x02013;281 &#x000b0;C; <sup>1</sup>H NMR (400
MHz, CDCl<sub>3</sub>) &#x003b4; 8.12 (d, <italic>J</italic> = 7.6 Hz,
2H), 7.51&#x02013;7.48 (m, 2H), 7.38&#x02013;7.37 (m, 2H), 7.26&#x02013;7.24
(m, 5H), 7.13&#x02013;7.10 (m, 2H), 2.98 (s, 2H), 2.71 (s, 2H), 2.05
(s, 3H), 1.17 (s, 6H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) &#x003b4; 159.2, 142.4, 139.8, 136.4, 134.1, 133.5, 132.4, 131.2,
129.2, 129.1, 128.9, 128.3, 126.0, 122.9, 122.3, 121.1, 115.4, 114.9,
104.4, 45.2, 37.1, 35.6, 29.0, 16.0; HRMS (ESI-TOF) <italic>m</italic>/<italic>z</italic> calcd for [M + H]<sup>+</sup> C<sub>32</sub>H<sub>27</sub>BrClN<sub>4</sub> 581.1107, found 581.1120.</p></sec><sec id="sec3.2.3.4"><title>1-(4-Chlorophenyl)-4,4,9-trimethyl-2,7-diphenyl-3,4,5,7-tetrahydro-2<italic>H</italic>-pyrazolo[3,4-<italic>b</italic>]pyrrolo[4,3,2-<italic>de</italic>]quinolone (<bold>7d</bold>)</title><p>Pale yellow solid
(216 mg, 43% yield): mp 271&#x02013;272 &#x000b0;C; <sup>1</sup>H NMR
(400 MHz, CDCl<sub>3</sub>) &#x003b4; 8.14 (d, <italic>J</italic> =
7.6 Hz, 2H), 7.49 (t, <italic>J</italic> = 8.0 Hz, 2H), 7.38&#x02013;7.36
(m, 3H), 7.30&#x02013;7.28 (m, 1H), 7.26&#x02013;7.22 (m, 4H), 7.12&#x02013;7.10
(m, 2H), 2.95 (s, 2H), 2.70 (s, 2H), 2.05 (s, 3H), 1.16 (s, 6H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) &#x003b4; 159.2, 142.3, 139.9,
137.4, 133.8, 133.6, 131.6, 129.1, 128.9, 128.30, 128.0, 127.7, 125.9,
122.8, 121.3, 115.2, 114.7, 104.6, 45.4, 37.1, 35.6, 29.0, 16.0; HRMS
(ESI-TOF) <italic>m</italic>/<italic>z</italic> calcd for [M + H]<sup>+</sup> C<sub>32</sub>H<sub>28</sub>ClN<sub>4</sub> 503.1996, found
503.2015.</p></sec><sec id="sec3.2.3.5"><title>1-(4-Chlorophenyl)-9-cyclopropyl-4,4-dimethyl-2,7-diphenyl-3,4,5,7-tetrahydro-2<italic>H</italic>-pyrazolo[3,4-<italic>b</italic>]pyrrolo[4,3,2-<italic>de</italic>]quinolone (<bold>7e</bold>)</title><p>Yellow solid (238
mg, 45% yield): mp 264&#x02013;265 &#x000b0;C; <sup>1</sup>H NMR (400
MHz, CDCl<sub>3</sub>) &#x003b4; 8.13 (d, <italic>J</italic> = 8.0 Hz,
2H), 7.49&#x02013;7.46 (m, 2H), 7.37&#x02013;7.36 (m, 3H), 7.29&#x02013;7.21
(m, 5H), 7.12&#x02013;7.10 (m, 2H), 2.96 (s, 2H), 2.71 (s, 2H), 1.37&#x02013;1.36
(m, 1H), 1.16 (s, 6H), 0.93&#x02013;0.92 (m, 2H), 0.51&#x02013;0.48
(m, 2H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) &#x003b4; 159.0,
147.2, 137.4, 133.5, 133.4, 133.1, 131.6, 129.1, 128.8, 128.3, 128.1,
127.8, 127.7, 125.9, 123.0, 122.7, 122.6, 115.3, 114.4, 105.0, 45.1,
37.2, 35.6, 28.9, 10.9, 7.9; HRMS (ESI-TOF) <italic>m</italic>/<italic>z</italic> calcd for [M + H]<sup>+</sup> C<sub>34</sub>H<sub>30</sub>ClN<sub>4</sub> 529.2153, found 529.2159.</p></sec><sec id="sec3.2.3.6"><title>4,4,7,9-Tetramethyl-1,2-di-<italic>p</italic>-tolyl-3,4,5,7-tetrahydro-2<italic>H</italic>-pyrazolo[3,4-<italic>b</italic>]pyrrolo[4,3,2-<italic>de</italic>]quinoline (<bold>7f</bold>)</title><p>White solid (169
mg, 39% yield): mp 255&#x02013;256 &#x000b0;C; <sup>1</sup>H NMR (400
MHz, DMSO-<italic>d</italic><sub>6</sub>) &#x003b4; 7.21&#x02013;7.18
(m, 4H), 7.13&#x02013;7.10 (m, 4H), 3.91 (s, 3H), 2.79 (s, 2H), 2.64
(s, 3H), 2.30 (s, 3H), 2.28 (s, 3H), 1.77 (s, 2H), 1.07 (s, 6H); <sup>13</sup>C NMR (100 MHz, DMSO-<italic>d</italic><sub>6</sub>) &#x003b4;
158.7, 148.9, 138.9, 137.7, 137.3, 132.5, 131.4, 130.3, 129.5, 128.7,
128.6, 128.2, 122.1, 114.5, 114.3, 102.7, 45.1, 36.8, 35.4, 34.3,
29.0, 21.3, 15.6; HRMS (ESI-TOF) <italic>m</italic>/<italic>z</italic> calcd for [M + H]<sup>+</sup> C<sub>29</sub>H<sub>31</sub>N<sub>4</sub> 435.2543, found 435.2541.</p></sec><sec id="sec3.2.3.7"><title>2-(4-Methoxyphenyl)-4,4,7,9-tetramethyl-1-(<italic>p</italic>-tolyl)-3,4,5,7-tetrahydro-2<italic>H</italic>-pyrazolo[3,4-<italic>b</italic>]pyrrolo[4,3,2-<italic>de</italic>]quinoline (<bold>7g</bold>)</title><p>White solid (202 mg, 45% yield): mp 240&#x02013;241 &#x000b0;C; <sup>1</sup>H NMR (400 MHz, DMSO-<italic>d</italic><sub>6</sub>) &#x003b4;
7.20 (s, 1H), 7.18 (d, <italic>J</italic> = 1.2 Hz, 2H), 7.15 (s,
1H), 7.11 (d, <italic>J</italic> = 8.0 Hz, 2H), 6.93 (d, <italic>J</italic> = 8.8 Hz, 2H), 3.91 (s, 3H), 3.76 (s, 3H), 2.78 (s, 2H), 2.62 (s,
2H), 2.28 (s, 3H), 1.77 (s, 3H), 1.07 (s, 6H); <sup>13</sup>C NMR
(100 MHz, DMSO-<italic>d</italic><sub>6</sub>) &#x003b4; 159.1, 158.6,
148.9, 138.9, 137.2, 132.6, 131.5, 130.4, 129.3, 128.7, 122.2, 114.6,
114.3, 114.1, 102.7, 55.8, 45.1, 36.7, 35.4, 34.3, 29.00, 21.3, 15.6;
HRMS (ESI-TOF) <italic>m</italic>/<italic>z</italic> calcd for [M
+ H]<sup>+</sup> C<sub>29</sub>H<sub>31</sub>N<sub>4</sub>O 451.2492,
found 451.2491.</p></sec><sec id="sec3.2.3.8"><title>4,4,7,9-Tetramethyl-2-phenyl-1-(<italic>p</italic>-tolyl)-3,4,5,7-tetrahydro-2<italic>H</italic>-pyrazolo[3,4-<italic>b</italic>]pyrrolo[4,3,2-<italic>de</italic>]quinolone (<bold>7h</bold>)</title><p>White solid (218
mg, 52% yield): mp 260&#x02013;261 &#x000b0;C; <sup>1</sup>H NMR (400
MHz, DMSO-<italic>d</italic><sub>6</sub>) &#x003b4; 7.40 (d, <italic>J</italic> = 7.6 Hz, 3H), 7.25&#x02013;7.18 (m, 4H), 7.10 (d, <italic>J</italic> = 7.6 Hz, 2H), 3.91 (s, 3H), 2.80 (s, 2H), 2.66 (s, 2H),
2.28 (s, 3H), 1.78 (s, 3H), 1.08 (s, 6H); <sup>13</sup>C NMR (100
MHz, CDCl<sub>3</sub>) &#x003b4; 158.8, 140.3, 137.7, 137.4, 132.1,
129.9, 128.9, 128.4, 127.9, 127.7, 122.7, 114.9, 114.4, 103.1, 45.2,
37.2, 35.5, 34.5, 29.0, 21.3, 15.5; HRMS (ESI-TOF) <italic>m</italic>/<italic>z</italic> calcd for [M + H]<sup>+</sup> C<sub>28</sub>H<sub>29</sub>N<sub>4</sub> 421.2386, found 421.2396.</p></sec><sec id="sec3.2.3.9"><title>2-(4-Bromophenyl)-4,4,7,9-tetramethyl-1-(<italic>p</italic>-tolyl)-3,4,5,7-tetrahydro-2<italic>H</italic>-pyrazolo[3,4-<italic>b</italic>]pyrrolo[4,3,2-<italic>de</italic>]quinoline (<bold>7i</bold>)</title><p>Yellow solid (189
mg, 38% yield): mp 280&#x02013;281 &#x000b0;C; <sup>1</sup>H NMR (400
MHz, DMSO-<italic>d</italic><sub>6</sub>) &#x003b4; 7.61 (d, <italic>J</italic> = 2.0 Hz, 1H), 7.60 (d, <italic>J</italic> = 2.0 Hz, 1H),
7.22&#x02013;7.19 (m, 4H), 7.14 (s, 2H), 3.91 (s, 3H), 2.79 (s, 2H),
2.67 (s, 2H), 2.30 (s, 3H), 1.78 (s, 3H), 1.08 (s, 6H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) &#x003b4; 158.7, 140.3, 137.7, 136.8,
132.1, 131.3, 129.6, 129.3, 129.2, 128.6, 127.7, 122.5, 121.9, 115.0,
114.7, 102.9, 45.2, 37.2, 35.5, 34.5, 28.9, 21.3, 15.4; HRMS (ESI-TOF) <italic>m</italic>/<italic>z</italic> calcd for [M + H]<sup>+</sup> C<sub>28</sub>H<sub>28</sub>BrN<sub>4</sub> 499.1491, found 499.1497.</p></sec><sec id="sec3.2.3.10"><title>1-(4-Bromophenyl)-4,4,7,9-tetramethyl-2-(<italic>p</italic>-tolyl)-3,4,5,7-tetrahydro-2<italic>H</italic>-pyrazolo[3,4-<italic>b</italic>]pyrrolo[4,3,2-<italic>de</italic>]quinolone (<bold>7j</bold>)</title><p>White solid (209
mg, 42% yield): mp 251&#x02013;252 &#x000b0;C; <sup>1</sup>H NMR (400
MHz, DMSO-<italic>d</italic><sub>6</sub>) &#x003b4; 7.51 (d, <italic>J</italic> = 2.0 Hz, 1H), 7.49 (d, <italic>J</italic> = 2.0 Hz, 1H),
7.27&#x02013;7.21 (m, 4H), 7.13 (d, <italic>J</italic> = 8.4 Hz, 2H),
3.92 (s, 3H), 2.80 (s, 2H), 2.65 (s, 2H), 2.32 (s, 3H), 1.83 (s, 3H),
1.08 (s, 6H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) &#x003b4;
158.7, 140.0, 138.3, 134.7, 133.7, 132.1, 130.9, 129.7, 129.3, 129.1,
127.3, 121.8, 121.1, 114.8, 114.8, 102.8, 45.2, 37.1, 35.5, 34.5,
28.9, 21.1, 15.9; HRMS (ESI-TOF) <italic>m</italic>/<italic>z</italic> calcd for [M + H]<sup>+</sup> C<sub>28</sub>H<sub>28</sub>BrN<sub>4</sub> 499.1491, found 499.1496.</p></sec><sec id="sec3.2.3.11"><title>1-(4-Bromophenyl)-4,4,7,9-tetramethyl-2-phenyl-3,4,5,7-tetrahydro-2<italic>H</italic>-pyrazolo[3,4-<italic>b</italic>]pyrrolo[4,3,2-<italic>de</italic>]quinoline (<bold>7k</bold>)</title><p>White solid (179
mg, 37% yield): mp 281&#x02013;282 &#x000b0;C; <sup>1</sup>H NMR (400
MHz, DMSO-<italic>d</italic><sub>6</sub>) &#x003b4; 7.51 (s, 1H), 7.49
(s, 1H), 7.43 (d, <italic>J</italic> = 7.6 Hz, 3H), 7.27&#x02013;7.25
(m, 4H), 3.93 (s, 3H), 2.82 (s, 2H), 2.68 (s, 2H), 1.85 (s, 3H), 1.09
(s, 6H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) &#x003b4; 158.8,
140.0, 137.4, 133.7, 132.0, 130.9, 129.2, 129.1, 128.8, 128.3, 127.7,
121.8, 121.1, 115.0, 114.9, 102.7, 45.2, 37.1, 35.5, 34.5, 28.9, 15.9;
HRMS (ESI-TOF) <italic>m</italic>/<italic>z</italic> calcd for [M
+ H]<sup>+</sup> C<sub>27</sub>H<sub>26</sub>BrN<sub>4</sub> 485.1335,
found 485.1370.</p></sec><sec id="sec3.2.3.12"><title>4,4,7,9-Tetramethyl-1-phenyl-2-(<italic>p</italic>-tolyl)-3,4,5,7-tetrahydro-2<italic>H</italic>-pyrazolo[3,4-<italic>b</italic>]pyrrolo[4,3,2-<italic>de</italic>]quinolone (<bold>7l</bold>)</title><p>White solid (227
mg, 54% yield): mp 280&#x02013;281 &#x000b0;C; <sup>1</sup>H NMR (400
MHz, DMSO-<italic>d</italic><sub>6</sub>) &#x003b4; 7.30 (s, 5H), 7.19
(d, <italic>J</italic> = 8.0 Hz, 2H), 7.12 (d, <italic>J</italic> =
8.4 Hz, 2H), 3.91 (s, 3H), 2.80 (s, 2H), 2.66 (s, 2H), 2.30 (s, 3H),
1.75 (s, 3H), 1.08 (s, 6H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) &#x003b4; 158.8, 140.2, 137.9, 135.1, 133.2, 132.3, 131.4,
129.5, 129.0, 127.6, 127.6, 127.4, 122.5, 114.8, 114.5, 102.9, 45.4,
37.2, 35.5, 34.5, 29.0, 21.1, 15.5; HRMS (ESI-TOF) <italic>m</italic>/<italic>z</italic> calcd for [M + H]<sup>+</sup> C<sub>28</sub>H<sub>29</sub>N<sub>4</sub> 421.2386, found 421.2397.</p></sec><sec id="sec3.2.3.13"><title>2-(3-Bromo-4-methylphenyl)-4,4,7,9-tetramethyl-1-phenyl-3,4,5,7-tetrahydro-2<italic>H</italic>-pyrazolo[3,4-<italic>b</italic>]pyrrolo[4,3,2-<italic>de</italic>]quinolone (<bold>7m</bold>)</title><p>White solid (204
mg, 41% yield): mp 276&#x02013;278 &#x000b0;C; <sup>1</sup>H NMR (400
MHz, DMSO-<italic>d</italic><sub>6</sub>) &#x003b4; 7.51 (d, <italic>J</italic> = 2.0 Hz, 1H), 7.37 (d, <italic>J</italic> = 8.0 Hz, 1H),
7.33 (s, 5H), 7.20 (dd, <italic>J</italic> = 8.0, 2.0 Hz, 1H), 3.91
(s, 3H), 2.80 (s, 2H), 2.69 (s, 2H), 1.74 (s, 3H), 1.09 (s, 6H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) &#x003b4; 158.8, 140.3, 138.0,
136.3, 132.7, 132.3, 131.1, 130.7, 128.5, 127.9, 127.8, 127.7, 126.4,
124.5, 122.5, 115.0, 114.7, 102.9, 45.1, 37.1, 35.5, 34.6, 29.0, 22.6,
15.3; HRMS (ESI-TOF) <italic>m</italic>/<italic>z</italic> calcd for
[M + H]<sup>+</sup> C<sub>28</sub>H<sub>28</sub>BrN<sub>4</sub> 499.1491,
found 499.1509.</p></sec><sec id="sec3.2.3.14"><title>2-(4-Bromophenyl)-4,4,7,9-tetramethyl-1-phenyl-3,4,5,7-tetrahydro-2<italic>H</italic>-pyrazolo[3,4-<italic>b</italic>]pyrrolo[4,3,2-<italic>de</italic>]quinoline (<bold>7n</bold>)</title><p>Yellow solid (208
mg, 43% yield): mp 279&#x02013;281 &#x000b0;C; <sup>1</sup>H NMR (400
MHz, DMSO-<italic>d</italic><sub>6</sub>) &#x003b4; 7.60 (d, <italic>J</italic> = 8.4 Hz, 2H), 7.32 (s, 5H), 7.22 (d, <italic>J</italic> = 8.4 Hz, 2H), 3.92 (s, 3H), 2.81 (s, 2H), 2.69 (s, 2H), 1.76 (s,
3H), 1.09 (s, 6H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>)
&#x003b4; 158.8, 140.2, 136.7, 132.7, 132.3, 132.2, 131.4, 131.2, 129.2,
128.0, 127.9, 122.4, 122.0, 115.1, 114.9, 102.8, 45.3, 37.2, 35.5,
34.5, 29.0, 15.4; HRMS (ESI-TOF) <italic>m</italic>/<italic>z</italic> calcd for [M + H]<sup>+</sup> C<sub>27</sub>H<sub>26</sub>BrN<sub>4</sub> 485.1335, found 485.1358.</p></sec><sec id="sec3.2.3.15"><title>1,2-Bis(4-methoxyphenyl)-4,4,7,9-tetramethyl-3,4,5,7-tetrahydro-2<italic>H</italic>-pyrazolo[3,4-<italic>b</italic>]pyrrolo[4,3,2-<italic>de</italic>]quinolone (<bold>7o</bold>)</title><p>Yellow solid (186
mg, 40% yield): mp 254&#x02013;256 &#x000b0;C; <sup>1</sup>H NMR (400
MHz, DMSO-<italic>d</italic><sub>6</sub>) &#x003b4; 7.24 (s, 1H), 7.22
(s, 1H), 7.17 (d, <italic>J</italic> = 8.8 Hz, 2H), 6.93 (d, <italic>J</italic> = 8.8 Hz, 2H), 6.86 (d, <italic>J</italic> = 8.8 Hz, 2H),
3.91 (s, 3H), 3.76 (s, 3H), 3.74 (s, 3H), 2.78 (s, 2H), 2.62 (s, 2H),
1.78 (s, 3H), 1.07 (s, 6H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) &#x003b4; 159.1, 159.0, 158.8, 140.1, 133.6, 131.2, 130.5,
128.7, 125.5, 122.3, 120.6, 114.6, 114.3, 114.0, 113.1, 103.0, 55.4,
55.2, 45.3, 37.1, 35.4, 34.5, 29.0, 15.4; HRMS (ESI-TOF) <italic>m</italic>/<italic>z</italic> calcd for [M + H]<sup>+</sup> C<sub>29</sub>H<sub>31</sub>N<sub>4</sub>O<sub>2</sub> 467.2441, found 467.2449.</p></sec><sec id="sec3.2.3.16"><title>9-Cyclopropyl-2-(4-methoxyphenyl)-7-methyl-1-(<italic>p</italic>-tolyl)-3,4,5,7-tetrahydro-2<italic>H</italic>-pyrazolo[3,4-<italic>b</italic>]pyrrolo[4,3,2-<italic>de</italic>]quinolone (<bold>7p</bold>)</title><p>Brown solid (206 mg, 46% yield): mp 272&#x02013;273 &#x000b0;C; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) &#x003b4; 7.20 (s, 1H), 7.18
(s, 1H), 7.04 (t, <italic>J</italic> = 8.4 Hz, 4H), 6.83 (d, <italic>J</italic> = 8.8 Hz, 2H), 4.08 (s, 3H), 3.80 (s, 3H), 3.13 (d, <italic>J</italic> = 17.6 Hz, 2H), 2.85 (d, <italic>J</italic> = 6.0 Hz,
2H), 2.30 (s, 5H), 1.36&#x02013;1.27 (m, 1H), 0.75&#x02013;0.73 (m,
2H), 0.30.36 (m, 2H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) &#x003b4; 159.4, 158.9, 145.3, 137.0, 132.1, 130.6, 130.1, 130.0,
128.7, 128.3, 128.2, 122.8, 115.8, 114.1, 114.0, 103.4, 55.4, 34.7,
24.4, 23.0, 21.3, 10.6, 7.4; HRMS (ESI-TOF) <italic>m</italic>/<italic>z</italic> calcd for [M + H]<sup>+</sup> C<sub>29</sub>H<sub>29</sub>N<sub>4</sub>O 449.2335, found 449.2340.</p></sec><sec id="sec3.2.3.17"><title>7,9-Dimethyl-1,2-di-<italic>p</italic>-tolyl-3,4,5,7-tetrahydro-2<italic>H</italic>-pyrazolo[3,4-<italic>b</italic>]pyrrolo[4,3,2-<italic>de</italic>]quinolone (<bold>7q</bold>)</title><p>Brown solid (142
mg, 35% yield): mp 274&#x02013;275 &#x000b0;C; <sup>1</sup>H NMR (400
MHz, CDCl<sub>3</sub>-<italic>d</italic>) &#x003b4; 7.16 (s, 1H), 7.14
(s, 1H), 7.07&#x02013;7.04 (m, 4H), 6.83 (d, <italic>J</italic> = 8.8
Hz, 2H), 4.10 (s, 3H), 3.80 (s, 3H), 3.12&#x02013;3.10 (m, 2H), 2.86
(t, <italic>J</italic> = 6.0 Hz, 2H), 2.33 (s, 3H), 2.31&#x02013;2.28
(m, 2H), 1.93 (s, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) &#x003b4; 159.5, 158.9, 140.2, 137.3, 132.2, 130.6, 130.0, 128.6,
128.4, 122.4, 115.7, 114.4, 114.0, 102.8, 55.4, 34.4, 31.3, 24.5,
23.0, 21.3, 15.5; HRMS (ESI-TOF) <italic>m</italic>/<italic>z</italic> calcd for [M + H]<sup>+</sup> C<sub>27</sub>H<sub>27</sub>N<sub>4</sub> 407.2230, found 407.2251.</p></sec></sec></sec></sec></body><back><notes id="notes-1" notes-type="si"><title>Supporting Information Available</title><p><sup>1</sup>H and <sup>13</sup>C NMR spectra for all pure products and X-ray crystal data
(CIF)
for <bold>5a</bold>, <bold>5q</bold>, and <bold>7d</bold>. This material
is available free of charge via the Internet at <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://pubs.acs.org">http://pubs.acs.org</uri>.</p></notes><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="sifile1"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jo502096t_si_001.pdf"><caption><p>jo502096t_si_001.pdf</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="sifile2"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jo502096t_si_002.cif"><caption><p>jo502096t_si_002.cif</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="sifile3"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jo502096t_si_003.cif"><caption><p>jo502096t_si_003.cif</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="sifile4"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jo502096t_si_004.cif"><caption><p>jo502096t_si_004.cif</p></caption></media></supplementary-material></sec><notes id="notes-2" notes-type="conflict-of-interest"><p>The authors
declare no competing financial interest.</p></notes><ack><title>Acknowledgments</title><p>We are
grateful for financial support from the NSFC (21332005,
21232004, 21272095, 21472071, and 21102124), the PAPD of Jiangsu Higher
Education Institutions, the Jiangsu Science and Technology Support
Program (BE2011045), the Qing Lan Project (12QLG006), the Robert A.
Welch Foundation (D-1361), and the National Institutes of Health (R33DA031860).</p></ack><ref-list><title>References</title><ref id="ref1"><mixed-citation publication-type="journal" id="cit1a"><label>a</label><name><surname>Melhado</surname><given-names>A. D.</given-names></name>; <name><surname>Brenzovitch</surname><given-names>W. E.</given-names></name>; <name><surname>Lackner</surname><given-names>A. D.</given-names></name>; <name><surname>Toste</surname><given-names>F. D.</given-names></name>
<source>J. Am. Chem. Soc.</source>
<year>2010</year>, <volume>132</volume>, <fpage>8885</fpage>.<pub-id pub-id-type="pmid">20557048</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit1b"><label> b</label><name><surname>Adams</surname><given-names>G. L.</given-names></name>; <name><surname>Carroll</surname><given-names>P. J.</given-names></name>; <name><surname>Smith</surname><given-names>A. B.</given-names><suffix>III.</suffix></name>
<source>J. Am. Chem. Soc.</source>
<year>2013</year>, <volume>135</volume>, <fpage>519</fpage>.<pub-id pub-id-type="pmid">23268611</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit1c"><label> c</label><name><surname>Snyder</surname><given-names>S. A.</given-names></name>; <name><surname>Breazzano</surname><given-names>S. P.</given-names></name>; <name><surname>Ross</surname><given-names>A. G.</given-names></name>; <name><surname>Lin</surname><given-names>Y.</given-names></name>; <name><surname>Zografos</surname><given-names>A. L.</given-names></name>
<source>J. Am. Chem. Soc.</source>
<year>2009</year>, <volume>131</volume>, <fpage>1753</fpage>.<pub-id pub-id-type="pmid">19143488</pub-id></mixed-citation></ref><ref id="ref2"><mixed-citation publication-type="journal" id="cit2a"><label>a</label><name><surname>Ondachi</surname><given-names>P. W.</given-names></name>; <name><surname>Comins</surname><given-names>D. L.</given-names></name>
<source>J. Org. Chem.</source>
<year>2010</year>, <volume>75</volume>, <fpage>1706</fpage>.<pub-id pub-id-type="pmid">20141225</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit2b"><label> b</label><name><surname>Inaba</surname><given-names>Y.</given-names></name>; <name><surname>Hasuda</surname><given-names>T.</given-names></name>; <name><surname>Hitotsuyanagi</surname><given-names>Y.</given-names></name>; <name><surname>Aoyagi</surname><given-names>Y.</given-names></name>; <name><surname>Fujikawa</surname><given-names>N.</given-names></name>; <name><surname>Onozaki</surname><given-names>A.</given-names></name>; <name><surname>Watanabe</surname><given-names>A.</given-names></name>; <name><surname>Kinoshita</surname><given-names>T.</given-names></name>; <name><surname>Takeya</surname><given-names>K.</given-names></name>
<source>J. Nat. Prod.</source>
<year>2013</year>, <volume>76</volume>, <fpage>1085</fpage>.<pub-id pub-id-type="pmid">23755851</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit2c"><label> c</label><name><surname>Bull</surname><given-names>J. A.</given-names></name>; <name><surname>Mousseau</surname><given-names>J. J.</given-names></name>; <name><surname>Pelletier</surname><given-names>G.</given-names></name>; <name><surname>Charette</surname><given-names>A. B.</given-names></name>
<source>Chem. Rev.</source>
<year>2012</year>, <volume>112</volume>, <fpage>2642</fpage>.<pub-id pub-id-type="pmid">22352938</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit2d"><label> d</label><name><surname>Montenegro</surname><given-names>H. E.</given-names></name>; <name><surname>Ramirez-Lopez</surname><given-names>P.</given-names></name>; <name><surname>de la Torre</surname><given-names>M. C.</given-names></name>; <name><surname>Asenjo</surname><given-names>M.</given-names></name>; <name><surname>Sierra</surname><given-names>M. A.</given-names></name>
<source>Chem.&#x02014;Eur. J.</source>
<year>2010</year>, <volume>16</volume>, <fpage>3798</fpage>.<pub-id pub-id-type="pmid">20162657</pub-id></mixed-citation></ref><ref id="ref3"><note><p>For isolation of oxerine, see:</p></note><mixed-citation publication-type="journal" id="cit3a"><label>a</label><name><surname>Benkrief</surname><given-names>R.</given-names></name>; <name><surname>Skaltsounis</surname><given-names>A.-L.</given-names></name>; <name><surname>Tillequin</surname><given-names>F.</given-names></name>; <name><surname>Koch</surname><given-names>M.</given-names></name>; <name><surname>Pusset</surname><given-names>J.</given-names></name>
<source>Planta Med.</source>
<year>1991</year>, <volume>57</volume>, <fpage>79</fpage>.<pub-id pub-id-type="pmid">17226124</pub-id></mixed-citation><note><p>For syntheses of oxerine, see:</p></note><mixed-citation publication-type="journal" id="cit3b"><label> b</label><name><surname>Aoyagi</surname><given-names>Y.</given-names></name>; <name><surname>Inariyama</surname><given-names>T.</given-names></name>; <name><surname>Arai</surname><given-names>Y.</given-names></name>; <name><surname>Tsuchida</surname><given-names>S.</given-names></name>; <name><surname>Matuda</surname><given-names>Y.</given-names></name>; <name><surname>Kobayashi</surname><given-names>H.</given-names></name>; <name><surname>Ohta</surname><given-names>A.</given-names></name>; <name><surname>Kurihara</surname><given-names>T.</given-names></name>; <name><surname>Fujihira</surname><given-names>S.</given-names></name>
<source>Tetrahedron</source>
<year>1994</year>, <volume>50</volume>, <fpage>13575</fpage>.</mixed-citation><mixed-citation publication-type="journal" id="cit3c"><label> c</label><name><surname>Jones</surname><given-names>K.</given-names></name>; <name><surname>Fiumana</surname><given-names>A.</given-names></name>
<source>Tetrahedron Lett.</source>
<year>1996</year>, <volume>37</volume>, <fpage>804</fpage>.</mixed-citation><mixed-citation publication-type="journal" id="cit3d"><label> d</label><name><surname>Jones</surname><given-names>K.</given-names></name>; <name><surname>Fiumana</surname><given-names>A.</given-names></name>; <name><surname>Escudero-Hernandez</surname><given-names>M. L.</given-names></name>
<source>Tetrahedron</source>
<year>2000</year>, <volume>56</volume>, <fpage>3976</fpage>.</mixed-citation><mixed-citation publication-type="journal" id="cit3e"><label> e</label><name><surname>Ohba</surname><given-names>M.</given-names></name>; <name><surname>Izuta</surname><given-names>R.</given-names></name>; <name><surname>Shimizu</surname><given-names>E.</given-names></name>
<source>Tetrahedron Lett.</source>
<year>2000</year>, <volume>41</volume>, <fpage>10251</fpage>.</mixed-citation><mixed-citation publication-type="journal" id="cit3f"><label> f</label><name><surname>Zhao</surname><given-names>J.</given-names></name>; <name><surname>Yang</surname><given-names>X.</given-names></name>; <name><surname>Jia</surname><given-names>X.</given-names></name>; <name><surname>Luo</surname><given-names>S.</given-names></name>; <name><surname>Zhai</surname><given-names>H.</given-names></name>
<source>Tetrahedron</source>
<year>2003</year>, <volume>59</volume>, <fpage>9379</fpage>.</mixed-citation></ref><ref id="ref4"><mixed-citation publication-type="journal" id="cit4"><name><surname>Sakan</surname><given-names>T.</given-names></name>; <name><surname>Fujino</surname><given-names>A.</given-names></name>; <name><surname>Murai</surname><given-names>F.</given-names></name>; <name><surname>Butsugan</surname><given-names>Y.</given-names></name>; <name><surname>Suzui</surname><given-names>A.</given-names></name>
<source>Bull.
Chem. Soc.
Jpn.</source>
<year>1959</year>, <volume>32</volume>, <fpage>315</fpage>.</mixed-citation></ref><ref id="ref5"><mixed-citation publication-type="journal" id="cit5a"><label>a</label><name><surname>Hattori</surname><given-names>M.</given-names></name>; <name><surname>Kawata</surname><given-names>Y.</given-names></name>; <name><surname>Inoue</surname><given-names>K.</given-names></name>; <name><surname>Shu</surname><given-names>Y.-Z.</given-names></name>; <name><surname>Che</surname><given-names>Q.-M.</given-names></name>; <name><surname>Namba</surname><given-names>T.</given-names></name>; <name><surname>Kobashi</surname><given-names>K.</given-names></name>
<source>Phytother. Res.</source>
<year>1990</year>, <volume>4</volume>, <fpage>66</fpage>.</mixed-citation><mixed-citation publication-type="journal" id="cit5b"><label> b</label><name><surname>Baghdikian</surname><given-names>B.</given-names></name>; <name><surname>Ollivier</surname><given-names>E.</given-names></name>; <name><surname>Faure</surname><given-names>R.</given-names></name>; <name><surname>Debrauwer</surname><given-names>L.</given-names></name>; <name><surname>Rathelot</surname><given-names>P.</given-names></name>; <name><surname>Balansard</surname><given-names>G.</given-names></name>
<source>J. Nat. Prod.</source>
<year>1999</year>, <volume>62</volume>, <fpage>211</fpage>.<pub-id pub-id-type="pmid">10075743</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit5c"><label> c</label><name><surname>Baghdikian</surname><given-names>B.</given-names></name>; <name><surname>Guiraud-Dauriac</surname><given-names>H.</given-names></name>; <name><surname>Ollivier</surname><given-names>E.</given-names></name>; <name><surname>N&#x02019;Guyen</surname><given-names>A.</given-names></name>; <name><surname>Dumenil</surname><given-names>G.</given-names></name>; <name><surname>Balansard</surname><given-names>G.</given-names></name>
<source>Planta Med.</source>
<year>1999</year>, <volume>65</volume>, <fpage>164</fpage>.<pub-id pub-id-type="pmid">10193209</pub-id></mixed-citation></ref><ref id="ref6"><mixed-citation publication-type="journal" id="cit6a"><label>a</label><name><surname>Cappelli</surname><given-names>A.</given-names></name>; <name><surname>Nannicini</surname><given-names>C.</given-names></name>; <name><surname>Gallelli</surname><given-names>A.</given-names></name>; <name><surname>Giuliani</surname><given-names>G.</given-names></name>; <name><surname>Valenti</surname><given-names>S.</given-names></name>; <name><surname>Mohr</surname><given-names>G. P.</given-names></name>; <name><surname>Anzini</surname><given-names>M.</given-names></name>; <name><surname>Mennuni</surname><given-names>L.</given-names></name>; <name><surname>Ferrari</surname><given-names>F.</given-names></name>; <name><surname>Caselli</surname><given-names>G.</given-names></name>; <name><surname>Giordani</surname><given-names>A.</given-names></name>; <name><surname>Pereis</surname><given-names>W.</given-names></name>; <name><surname>Makovec</surname><given-names>F.</given-names></name>; <name><surname>Giorgi</surname><given-names>G.</given-names></name>; <name><surname>Vomero</surname><given-names>S.</given-names></name>
<source>J. Med. Chem.</source>
<year>2008</year>, <volume>51</volume>, <fpage>2137</fpage>.<pub-id pub-id-type="pmid">18318468</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit6b"><label> b</label><name><surname>de
Mello</surname><given-names>H.</given-names></name>; <name><surname>Echevarria</surname><given-names>A.</given-names></name>; <name><surname>Bernardino</surname><given-names>A. M.</given-names></name>; <name><surname>Canto-Cavalheiro</surname><given-names>M.</given-names></name>; <name><surname>Leon</surname><given-names>L. L.</given-names></name>
<source>J. Med. Chem.</source>
<year>2004</year>, <volume>47</volume>, <fpage>5427</fpage>.<pub-id pub-id-type="pmid">15481980</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit6c"><label> c</label><name><surname>Tuccinardi</surname><given-names>T.</given-names></name>; <name><surname>Schenone</surname><given-names>S.</given-names></name>; <name><surname>Bondavalli</surname><given-names>F.</given-names></name>; <name><surname>Brullo</surname><given-names>C.</given-names></name>; <name><surname>Bruno</surname><given-names>O.</given-names></name>; <name><surname>Mosti</surname><given-names>L.</given-names></name>; <name><surname>Zizzari</surname><given-names>A. T.</given-names></name>; <name><surname>Tintori</surname><given-names>C.</given-names></name>; <name><surname>Manetti</surname><given-names>F.</given-names></name>; <name><surname>Ciampi</surname><given-names>O.</given-names></name>; <name><surname>Trincavelli</surname><given-names>M. L.</given-names></name>; <name><surname>Martini</surname><given-names>C.</given-names></name>; <name><surname>Martinelli</surname><given-names>A.</given-names></name>; <name><surname>Botta</surname><given-names>M.</given-names></name>
<source>ChemMedChem</source>
<year>2008</year>, <volume>3</volume>, <fpage>898</fpage>.<pub-id pub-id-type="pmid">18338422</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit6d"><label> d</label><name><surname>Manetti</surname><given-names>F.</given-names></name>; <name><surname>Schenone</surname><given-names>S.</given-names></name>; <name><surname>Bondavalli</surname><given-names>F.</given-names></name>; <name><surname>Brullo</surname><given-names>C.</given-names></name>; <name><surname>Bruno</surname><given-names>O.</given-names></name>; <name><surname>Ranise</surname><given-names>A.</given-names></name>; <name><surname>Mosti</surname><given-names>L.</given-names></name>; <name><surname>Menozzi</surname><given-names>G.</given-names></name>; <name><surname>Fossa</surname><given-names>P.</given-names></name>; <name><surname>Trincavelli</surname><given-names>M. L.</given-names></name>; <name><surname>Martini</surname><given-names>C.</given-names></name>; <name><surname>Martinelli</surname><given-names>A.</given-names></name>; <name><surname>Tintori</surname><given-names>C.</given-names></name>; <name><surname>Botta</surname><given-names>M.</given-names></name>
<source>J. Med. Chem.</source>
<year>2005</year>, <volume>48</volume>, <fpage>7172</fpage>.<pub-id pub-id-type="pmid">16279775</pub-id></mixed-citation></ref><ref id="ref7"><mixed-citation publication-type="journal" id="cit7a"><label>a</label><name><surname>Lin</surname><given-names>R.</given-names></name>; <name><surname>Connolly</surname><given-names>P. J.</given-names></name>; <name><surname>Lu</surname><given-names>Y.</given-names></name>; <name><surname>Chiu</surname><given-names>G.</given-names></name>; <name><surname>Li</surname><given-names>S.</given-names></name>; <name><surname>Yu</surname><given-names>Y.</given-names></name>; <name><surname>Huang</surname><given-names>S.</given-names></name>; <name><surname>Li</surname><given-names>X.</given-names></name>; <name><surname>Emanuel</surname><given-names>S. L.</given-names></name>; <name><surname>Middleton</surname><given-names>S. A.</given-names></name>; <name><surname>Gruninger</surname><given-names>R. H.</given-names></name>; <name><surname>Adams</surname><given-names>M.</given-names></name>; <name><surname>Fuentes-Pesquera</surname><given-names>A. R.</given-names></name>; <name><surname>Greenberger</surname><given-names>L. M.</given-names></name>
<source>Bioorg. Med. Chem. Lett.</source>
<year>2007</year>, <volume>17</volume>, <fpage>4297</fpage>.<pub-id pub-id-type="pmid">17532631</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit7b"><label> b</label><name><surname>Witherington</surname><given-names>J.</given-names></name>; <name><surname>Bordas</surname><given-names>V.</given-names></name>; <name><surname>Garland</surname><given-names>S. L.</given-names></name>; <name><surname>Hickey</surname><given-names>D. M. B.</given-names></name>; <name><surname>Ife</surname><given-names>R. J.</given-names></name>; <name><surname>Liddle</surname><given-names>J.</given-names></name>; <name><surname>Saunders</surname><given-names>M.</given-names></name>; <name><surname>Smith</surname><given-names>D. G.</given-names></name>; <name><surname>Ward</surname><given-names>R. W.</given-names></name>
<source>Bioorg. Med. Chem.
Lett.</source>
<year>2003</year>, <volume>13</volume>, <fpage>1577</fpage>.<pub-id pub-id-type="pmid">12699759</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit7c"><label> c</label><name><surname>Revesz</surname><given-names>L.</given-names></name>; <name><surname>Blum</surname><given-names>E.</given-names></name>; <name><surname>Di Padova</surname><given-names>F. E.</given-names></name>; <name><surname>Buhl</surname><given-names>T.</given-names></name>; <name><surname>Feifel</surname><given-names>R.</given-names></name>; <name><surname>Gram</surname><given-names>H.</given-names></name>; <name><surname>Hiestand</surname><given-names>P.</given-names></name>; <name><surname>Manning</surname><given-names>U.</given-names></name>; <name><surname>Neumann</surname><given-names>U.</given-names></name>; <name><surname>Rucklin</surname><given-names>G.</given-names></name>
<source>Bioorg. Med. Chem. Lett.</source>
<year>2006</year>, <volume>16</volume>, <fpage>262</fpage>.<pub-id pub-id-type="pmid">16249085</pub-id></mixed-citation></ref><ref id="ref8"><mixed-citation publication-type="journal" id="cit8a"><label>a</label><name><surname>Sezer</surname><given-names>S.</given-names></name>; <name><surname>Gumrukcu</surname><given-names>Y.</given-names></name>; <name><surname>Bakirci</surname><given-names>I.</given-names></name>; <name><surname>Yagiz Unver</surname><given-names>M.</given-names></name>; <name><surname>Tanyeli</surname><given-names>C.</given-names></name>
<source>Tetrahedron: Asymmetry</source>
<year>2012</year>, <volume>23</volume>, <fpage>662</fpage>.</mixed-citation><mixed-citation publication-type="journal" id="cit8b"><label> b</label><name><surname>Bonaga</surname><given-names>L. V. R.</given-names></name>; <name><surname>Zhang</surname><given-names>H.-C.</given-names></name>; <name><surname>Maryanoff</surname><given-names>B. E.</given-names></name>
<source>Chem. Commun.</source>
<year>2004</year>, <fpage>2394</fpage>.</mixed-citation><mixed-citation publication-type="journal" id="cit8c"><label> c</label><name><surname>Deprele</surname><given-names>S.</given-names></name>; <name><surname>Kashemirov</surname><given-names>B. A.</given-names></name>; <name><surname>Hogan</surname><given-names>J. M.</given-names></name>; <name><surname>Ebetino</surname><given-names>F. H.</given-names></name>; <name><surname>Barnett</surname><given-names>B. L.</given-names></name>; <name><surname>Evdokimov</surname><given-names>A.</given-names></name>; <name><surname>McKenna</surname><given-names>C. E.</given-names></name>
<source>Bioorg. Med. Chem. Lett.</source>
<year>2008</year>, <volume>18</volume>, <fpage>2878</fpage>.<pub-id pub-id-type="pmid">18434151</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit8d"><label> d</label><name><surname>Dotsenko</surname><given-names>V. V.</given-names></name>; <name><surname>Krivokolysko</surname><given-names>S. G.</given-names></name>; <name><surname>Litvinov</surname><given-names>V. P.</given-names></name>
<source>Monatsh. Chem.</source>
<year>2008</year>, <volume>139</volume>, <fpage>271</fpage>.</mixed-citation><mixed-citation publication-type="journal" id="cit8e"><label> e</label><name><surname>Robert</surname><given-names>N.</given-names></name>; <name><surname>Hoarau</surname><given-names>C.</given-names></name>; <name><surname>Marsais</surname><given-names>F.</given-names></name>
<source>Tetrahedron</source>
<year>2007</year>, <volume>63</volume>, <fpage>3702</fpage>&#x02013;<lpage>3706</lpage>.</mixed-citation><mixed-citation publication-type="journal" id="cit8f"><label> f</label><name><surname>Zhao</surname><given-names>J.</given-names></name>; <name><surname>Yang</surname><given-names>X.</given-names></name>; <name><surname>Jia</surname><given-names>X.</given-names></name>; <name><surname>Luo</surname><given-names>S.</given-names></name>; <name><surname>Zhai</surname><given-names>H.</given-names></name>
<source>Tetrahedron</source>
<year>2003</year>, <volume>59</volume>, <fpage>9379</fpage>.</mixed-citation><mixed-citation publication-type="journal" id="cit8g"><label> g</label><name><surname>Guenter</surname><given-names>M.</given-names></name>; <name><surname>Gais</surname><given-names>H.-J.</given-names></name>
<source>J. Org. Chem.</source>
<year>2003</year>, <volume>68</volume>, <fpage>8037</fpage>.<pub-id pub-id-type="pmid">14535780</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit8h"><label> h</label><name><surname>Ohba</surname><given-names>M.</given-names></name>; <name><surname>Izuta</surname><given-names>R.</given-names></name>
<source>Heterocycles</source>
<year>2001</year>, <volume>55</volume>, <fpage>823</fpage>.</mixed-citation><mixed-citation publication-type="journal" id="cit8i"><label> i</label><name><surname>Ohba</surname><given-names>M.</given-names></name>; <name><surname>Izuta</surname><given-names>R.</given-names></name>; <name><surname>Shimizu</surname><given-names>E.</given-names></name>
<source>Tetrahedron Lett.</source>
<year>2000</year>, <volume>41</volume>, <fpage>10251</fpage>.</mixed-citation><mixed-citation publication-type="journal" id="cit8j"><label> j</label><name><surname>Jones</surname><given-names>K.</given-names></name>; <name><surname>Fiumana</surname><given-names>A.</given-names></name>
<source>Tetrahedron Lett.</source>
<year>1996</year>, <volume>37</volume>, <fpage>8049</fpage>.</mixed-citation></ref><ref id="ref9"><mixed-citation publication-type="journal" id="cit9a"><label>a</label><name><surname>Shekarrao</surname><given-names>K.</given-names></name>; <name><surname>Kaishap</surname><given-names>P. P.</given-names></name>; <name><surname>Saddanapu</surname><given-names>V.</given-names></name>; <name><surname>Addlagatta</surname><given-names>A.</given-names></name>; <name><surname>Gogoi</surname><given-names>S.</given-names></name>; <name><surname>Boruah</surname><given-names>R. C.</given-names></name>
<source>RSC Adv.</source>
<year>2014</year>, <volume>4</volume>, <fpage>24001</fpage>.</mixed-citation><mixed-citation publication-type="journal" id="cit9b"><label> b</label><name><surname>Dodiya</surname><given-names>D. K.</given-names></name>; <name><surname>Trivedi</surname><given-names>A. R.</given-names></name>; <name><surname>Kataria</surname><given-names>V. B.</given-names></name>; <name><surname>Shah</surname><given-names>V. H.</given-names></name>
<source>Curr. Org. Chem.</source>
<year>2012</year>, <volume>16</volume>, <fpage>400</fpage>.</mixed-citation><mixed-citation publication-type="journal" id="cit9c"><label> c</label><name><surname>El-borai</surname><given-names>M. A.</given-names></name>; <name><surname>Rizk</surname><given-names>H. F.</given-names></name>; <name><surname>Abd-Aal</surname><given-names>M. F.</given-names></name>; <name><surname>El-Deeb</surname><given-names>I. Y.</given-names></name>
<source>Eur. J. Med. Chem.</source>
<year>2012</year>, <volume>48</volume>, <fpage>92</fpage>.<pub-id pub-id-type="pmid">22178093</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit9d"><label> d</label><name><surname>Kendre</surname><given-names>D. B.</given-names></name>; <name><surname>Toche</surname><given-names>R. B.</given-names></name>; <name><surname>Jachak</surname><given-names>M. N.</given-names></name>
<source>J. Heterocycl. Chem.</source>
<year>2008</year>, <volume>45</volume>, <fpage>1281</fpage>.</mixed-citation><mixed-citation publication-type="journal" id="cit9e"><label> e</label><name><surname>Diaz-Ortiz</surname><given-names>A.</given-names></name>; <name><surname>Carrillo</surname><given-names>J. R.</given-names></name>; <name><surname>Cossio</surname><given-names>F. P.</given-names></name>; <name><surname>Gomez-Escalonilla</surname><given-names>M. J.</given-names></name>; <name><surname>De la Hoz</surname><given-names>A.</given-names></name>; <name><surname>Moreno</surname><given-names>A.</given-names></name>; <name><surname>Prieto</surname><given-names>P.</given-names></name>
<source>Tetrahedron</source>
<year>2000</year>, <volume>56</volume>, <fpage>1569</fpage>.</mixed-citation></ref><ref id="ref10"><mixed-citation publication-type="journal" id="cit10"><name><surname>Winters</surname><given-names>G.</given-names></name>; <name><surname>Schiatti</surname><given-names>P.</given-names></name>; <name><surname>Selva</surname><given-names>D.</given-names></name>
<source>Farmaco, Ed. Sci.</source>
<year>1985</year>, <volume>40</volume>, <fpage>845</fpage>.</mixed-citation></ref><ref id="ref11"><note><p>For reviews, see:</p></note><mixed-citation publication-type="journal" id="cit11a"><label>a</label><name><surname>Groenendaal</surname><given-names>B.</given-names></name>; <name><surname>Ruijter</surname><given-names>E.</given-names></name>; <name><surname>Orru</surname><given-names>R. V. A.</given-names></name>
<source>Chem. Commun.</source>
<year>2008</year>, <fpage>5474</fpage>.</mixed-citation><mixed-citation publication-type="journal" id="cit11b"><label> b</label><name><surname>Padwa</surname><given-names>A.</given-names></name>
<source>Chem.
Soc. Rev.</source>
<year>2009</year>, <volume>38</volume>, <fpage>3072</fpage>.<pub-id pub-id-type="pmid">19847342</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit11c"><label> c</label><name><surname>Tietze</surname><given-names>L. F.</given-names></name>; <name><surname>Kinzel</surname><given-names>T.</given-names></name>; <name><surname>Brazel</surname><given-names>C. C.</given-names></name>
<source>Acc. Chem. Res.</source>
<year>2009</year>, <volume>42</volume>, <fpage>367</fpage>.<pub-id pub-id-type="pmid">19154154</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit11d"><label> d</label><name><surname>Domling</surname><given-names>A.</given-names></name>; <name><surname>Wang</surname><given-names>W.</given-names></name>; <name><surname>Wang</surname><given-names>K.</given-names></name>
<source>Chem. Rev.</source>
<year>2012</year>, <volume>112</volume>, <fpage>3083</fpage>.<pub-id pub-id-type="pmid">22435608</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit11e"><label> e</label><name><surname>Ruijter</surname><given-names>E.</given-names></name>; <name><surname>Scheffelaar</surname><given-names>R.</given-names></name>; <name><surname>Orru</surname><given-names>R. V. A.</given-names></name>
<source>Angew. Chem., Int. Ed.</source>
<year>2011</year>, <volume>50</volume>, <fpage>6234</fpage>.</mixed-citation><mixed-citation publication-type="journal" id="cit11f"><label> f</label><name><surname>Jiang</surname><given-names>B.</given-names></name>; <name><surname>Rajale</surname><given-names>T.</given-names></name>; <name><surname>Wever</surname><given-names>W.</given-names></name>; <name><surname>Tu</surname><given-names>S.-J.</given-names></name>; <name><surname>Li</surname><given-names>G.</given-names></name>
<source>Chem.&#x02014;Asian
J.</source>
<year>2010</year>, <volume>5</volume>, <fpage>2318</fpage>.<pub-id pub-id-type="pmid">20922748</pub-id></mixed-citation></ref><ref id="ref12"><mixed-citation publication-type="book" id="cit12a"><label>a</label><person-group person-group-type="allauthors"><name><surname>Tietze</surname><given-names>L. F.</given-names></name>; <name><surname>Brasche</surname><given-names>G.</given-names></name>; <name><surname>Gerike</surname><given-names>K.</given-names></name></person-group><source>Domino Reactions in Organic Chemistry</source>; <publisher-name>Wiley-VCH</publisher-name>: <publisher-loc>Weinheim,
Germany</publisher-loc>, <year>2006</year>.</mixed-citation><mixed-citation publication-type="book" id="cit12b"><label>b</label><person-group person-group-type="allauthors"><name><surname>Zhu</surname><given-names>J. P.</given-names></name>; <name><surname>Bienayme</surname><given-names>H.</given-names></name></person-group><source>Multicomponent
Reactions</source>; <publisher-name>Wiley-VCH</publisher-name>: <publisher-loc>Weinheim, Germany</publisher-loc>, <year>2004</year>.</mixed-citation><mixed-citation publication-type="journal" id="cit12c"><label>c</label><name><surname>Toure</surname><given-names>B. B.</given-names></name>; <name><surname>Hall</surname><given-names>D. G.</given-names></name>
<source>Chem. Rev.</source>
<year>2009</year>, <volume>109</volume>, <fpage>4439</fpage>.<pub-id pub-id-type="pmid">19480390</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit12d"><label> d</label><name><surname>Ganem</surname><given-names>B.</given-names></name>
<source>Acc. Chem. Res.</source>
<year>2009</year>, <volume>42</volume>, <fpage>463</fpage>.<pub-id pub-id-type="pmid">19175315</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit12e"><label> e</label><name><surname>Ismabery</surname><given-names>N.</given-names></name>; <name><surname>Lavila</surname><given-names>R.</given-names></name>
<source>Chem.&#x02014;Eur. J.</source>
<year>2008</year>, <volume>14</volume>, <fpage>8444</fpage>.<pub-id pub-id-type="pmid">18576454</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit12f"><label> f</label><name><surname>Tietze</surname><given-names>L. F.</given-names></name>
<source>Chem. Rev.</source>
<year>1996</year>, <volume>96</volume>, <fpage>115</fpage>.<pub-id pub-id-type="pmid">11848746</pub-id></mixed-citation></ref><ref id="ref13"><mixed-citation publication-type="journal" id="cit13a"><label>a</label><name><surname>Li</surname><given-names>M.</given-names></name>; <name><surname>Shao</surname><given-names>P.</given-names></name>; <name><surname>Wang</surname><given-names>S.-W.</given-names></name>; <name><surname>Kong</surname><given-names>W.</given-names></name>; <name><surname>Wen</surname><given-names>L.-R.</given-names></name>
<source>J. Org. Chem.</source>
<year>2012</year>, <volume>77</volume>, <fpage>8956</fpage>.<pub-id pub-id-type="pmid">22970749</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit13b"><label> b</label><name><surname>Terzidis</surname><given-names>M. A.</given-names></name>; <name><surname>Zarganes-Tzitzikas</surname><given-names>T.</given-names></name>; <name><surname>Tsimenidis</surname><given-names>C.</given-names></name>; <name><surname>Stephanidou-Stephanatou</surname><given-names>J.</given-names></name>; <name><surname>Tsoleridis</surname><given-names>C. A.</given-names></name>; <name><surname>Kostakis</surname><given-names>G. E.</given-names></name>
<source>J. Org. Chem.</source>
<year>2012</year>, <volume>77</volume>, <fpage>9018</fpage>.<pub-id pub-id-type="pmid">22978377</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit13c"><label> c</label><name><surname>Ausmees</surname><given-names>K.</given-names></name>; <name><surname>Kriis</surname><given-names>K.</given-names></name>; <name><surname>Pehk</surname><given-names>T.</given-names></name>; <name><surname>Werner</surname><given-names>F.</given-names></name>; <name><surname>J&#x000e4;rving</surname><given-names>I.</given-names></name>; <name><surname>Lopp</surname><given-names>M.</given-names></name>; <name><surname>Kanger</surname><given-names>T.</given-names></name>
<source>J. Org. Chem.</source>
<year>2012</year>, <volume>77</volume>, <fpage>10680</fpage>.<pub-id pub-id-type="pmid">23113764</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit13d"><label> d</label><name><surname>Sun</surname><given-names>J.</given-names></name>; <name><surname>Sun</surname><given-names>Y.</given-names></name>; <name><surname>Gong</surname><given-names>H.</given-names></name>; <name><surname>Xie</surname><given-names>Y.-J.</given-names></name>; <name><surname>Yan</surname><given-names>C.-G.</given-names></name>
<source>Org. Lett.</source>
<year>2012</year>, <volume>14</volume>, <fpage>5172</fpage>.<pub-id pub-id-type="pmid">23050691</pub-id></mixed-citation></ref><ref id="ref14"><mixed-citation publication-type="journal" id="cit14a"><label>a</label><name><surname>Fan</surname><given-names>W.</given-names></name>; <name><surname>Ye</surname><given-names>Q.</given-names></name>; <name><surname>Xu</surname><given-names>H.-W.</given-names></name>; <name><surname>Jiang</surname><given-names>B.</given-names></name>; <name><surname>Wang</surname><given-names>S.-L.</given-names></name>; <name><surname>Tu</surname><given-names>S.-J.</given-names></name>
<source>Org. Lett.</source>
<year>2013</year>, <volume>15</volume>, <fpage>2258</fpage>.<pub-id pub-id-type="pmid">23597067</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit14b"><label> b</label><name><surname>Jiang</surname><given-names>B.</given-names></name>; <name><surname>Wang</surname><given-names>X.</given-names></name>; <name><surname>Xu</surname><given-names>H.-W.</given-names></name>; <name><surname>Tu</surname><given-names>M.-S.</given-names></name>; <name><surname>Tu</surname><given-names>S.-J.</given-names></name>; <name><surname>Li</surname><given-names>G.</given-names></name>
<source>Org. Lett.</source>
<year>2013</year>, <volume>15</volume>, <fpage>1540</fpage>.<pub-id pub-id-type="pmid">23506186</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit14c"><label> c</label><name><surname>Jiang</surname><given-names>B.</given-names></name>; <name><surname>Feng</surname><given-names>B.-M.</given-names></name>; <name><surname>Wang</surname><given-names>S.-L.</given-names></name>; <name><surname>Tu</surname><given-names>S.-J.</given-names></name>; <name><surname>Li</surname><given-names>G.</given-names></name>
<source>Chem.&#x02014;Eur. J.</source>
<year>2012</year>, <volume>18</volume>, <fpage>9823</fpage>.<pub-id pub-id-type="pmid">22767331</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit14d"><label> d</label><name><surname>Jiang</surname><given-names>B.</given-names></name>; <name><surname>Tu</surname><given-names>S.-J.</given-names></name>; <name><surname>Kaur</surname><given-names>P.</given-names></name>; <name><surname>Wever</surname><given-names>W.</given-names></name>; <name><surname>Li</surname><given-names>G.</given-names></name>
<source>J. Am.
Chem. Soc.</source>
<year>2009</year>, <volume>131</volume>, <fpage>11660</fpage>.<pub-id pub-id-type="pmid">19722590</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit14e"><label> e</label><name><surname>Li</surname><given-names>T.-J.</given-names></name>; <name><surname>Yin</surname><given-names>H.-M.</given-names></name>; <name><surname>Yao</surname><given-names>C.-S.</given-names></name>; <name><surname>Wang</surname><given-names>X.-S.</given-names></name>; <name><surname>Jiang</surname><given-names>B.</given-names></name>; <name><surname>Tu</surname><given-names>S.-J.</given-names></name>; <name><surname>Li</surname><given-names>G.</given-names></name>
<source>Chem. Commun.</source>
<year>2012</year>, <fpage>11966</fpage>.</mixed-citation><mixed-citation publication-type="journal" id="cit14f"><label> f</label><name><surname>Jiang</surname><given-names>B.</given-names></name>; <name><surname>Li</surname><given-names>C.</given-names></name>; <name><surname>Shi</surname><given-names>F.</given-names></name>; <name><surname>Tu</surname><given-names>S.-J.</given-names></name>; <name><surname>Kaur</surname><given-names>P.</given-names></name>; <name><surname>Wever</surname><given-names>W.</given-names></name>; <name><surname>Li</surname><given-names>G.</given-names></name>
<source>J. Org. Chem.</source>
<year>2010</year>, <volume>75</volume>, <fpage>296</fpage>.<pub-id pub-id-type="pmid">20020697</pub-id></mixed-citation></ref><ref id="ref15"><mixed-citation publication-type="journal" id="cit15a"><label>a</label><name><surname>Raikar</surname><given-names>S. N.</given-names></name>; <name><surname>Malinakova</surname><given-names>H. C.</given-names></name>
<source>J. Org. Chem.</source>
<year>2013</year>, <volume>78</volume>, <fpage>3832</fpage>.<pub-id pub-id-type="pmid">23521584</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit15b"><label> b</label><name><surname>Xia</surname><given-names>L.</given-names></name>; <name><surname>Li</surname><given-names>S.</given-names></name>; <name><surname>Chen</surname><given-names>R.-J.</given-names></name>; <name><surname>Liu</surname><given-names>K.</given-names></name>; <name><surname>Chen</surname><given-names>X.-C.</given-names></name>
<source>J. Org. Chem.</source>
<year>2013</year>, <volume>78</volume>, <fpage>3120</fpage>.<pub-id pub-id-type="pmid">23442048</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit15c"><label> c</label><name><surname>Wang</surname><given-names>X.</given-names></name>; <name><surname>Wang</surname><given-names>S.-Y.</given-names></name>; <name><surname>Ji</surname><given-names>S.-J.</given-names></name>
<source>Org. Lett.</source>
<year>2013</year>, <volume>15</volume>, <fpage>1954</fpage>.<pub-id pub-id-type="pmid">23565712</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit15d"><label> d</label><name><surname>Qian</surname><given-names>W.-Y.</given-names></name>; <name><surname>Amegadzie</surname><given-names>A.</given-names></name>; <name><surname>Winternheimer</surname><given-names>D.</given-names></name>; <name><surname>Allen</surname><given-names>J.</given-names></name>
<source>Org.
Lett.</source>
<year>2013</year>, <volume>15</volume>, <fpage>2986</fpage>.<pub-id pub-id-type="pmid">23751086</pub-id></mixed-citation><mixed-citation publication-type="journal" id="cit15e"><label> e</label><name><surname>Xu</surname><given-names>Z.-G.</given-names></name>; <name><surname>Moline</surname><given-names>F. D.</given-names></name>; <name><surname>Cappelli</surname><given-names>A. P.</given-names></name>; <name><surname>Hulme</surname><given-names>C.</given-names></name>
<source>Org. Lett.</source>
<year>2013</year>, <volume>15</volume>, <fpage>2738</fpage>.<pub-id pub-id-type="pmid">23718233</pub-id></mixed-citation></ref><ref id="ref16"><mixed-citation publication-type="journal" id="cit16"><name><surname>Jiang</surname><given-names>B.</given-names></name>; <name><surname>Ye</surname><given-names>Q.</given-names></name>; <name><surname>Fan</surname><given-names>W.</given-names></name>; <name><surname>Wang</surname><given-names>S.-L.</given-names></name>; <name><surname>Tu</surname><given-names>S.-J.</given-names></name>; <name><surname>Li</surname><given-names>G.</given-names></name>
<source>Chem. Commun.</source>
<year>2014</year>, <volume>50</volume>, <fpage>6108</fpage>.</mixed-citation></ref><ref id="ref17"><mixed-citation publication-type="journal" id="cit17a"><label>a</label><name><surname>De March</surname><given-names>P.</given-names></name>; <name><surname>Moreno-Manas</surname><given-names>M.</given-names></name>; <name><surname>Roca</surname><given-names>J. L.</given-names></name>
<source>J. Heterocycl. Chem.</source>
<year>1984</year>, <volume>21</volume>, <fpage>1371</fpage>.</mixed-citation><mixed-citation publication-type="journal" id="cit17b"><label> b</label><name><surname>Svetlik</surname><given-names>J.</given-names></name>; <name><surname>Pronayova</surname><given-names>N.</given-names></name>; <name><surname>Hanus</surname><given-names>V.</given-names></name>
<source>J.
Heterocycl. Chem.</source>
<year>2000</year>, <volume>37</volume>, <fpage>395</fpage>.</mixed-citation><mixed-citation publication-type="journal" id="cit17c"><label> c</label><name><surname>Grigoryeva</surname><given-names>O. A.</given-names></name>; <name><surname>Fedotova</surname><given-names>O. V.</given-names></name>; <name><surname>Shkel</surname><given-names>A. A.</given-names></name>
<source>Chem. Heterocycl.
Compd.</source>
<year>2011</year>, <volume>46</volume>, <fpage>1509</fpage>.</mixed-citation><mixed-citation publication-type="journal" id="cit17d"><label> d</label><name><surname>Gelin</surname><given-names>S.</given-names></name>; <name><surname>Chantegrel</surname><given-names>B.</given-names></name>; <name><surname>Nadi</surname><given-names>A. I.</given-names></name>
<source>J. Org. Chem.</source>
<year>1983</year>, <volume>48</volume>, <fpage>4078</fpage>.</mixed-citation><mixed-citation publication-type="journal" id="cit17e"><label> e</label><name><surname>Jiang</surname><given-names>B.</given-names></name>; <name><surname>Feng</surname><given-names>B.-M.</given-names></name>; <name><surname>Wang</surname><given-names>S.-L.</given-names></name>; <name><surname>Tu</surname><given-names>S.-J.</given-names></name>; <name><surname>Li</surname><given-names>G.</given-names></name>
<source>Chem.&#x02014;Eur.
J.</source>
<year>2012</year>, <volume>18</volume>, <fpage>9823</fpage>.<pub-id pub-id-type="pmid">22767331</pub-id></mixed-citation></ref><ref id="ref18"><mixed-citation publication-type="journal" id="cit18"><comment>For the preparation
of 6-methyl-1-phenylpyridine-2,4(1<italic>H</italic>,3<italic>H</italic>)-dione <bold>8</bold>, see:</comment><name><surname>Selness</surname><given-names>S. R.</given-names></name>; <name><surname>Boehm</surname><given-names>T. L.</given-names></name>; <name><surname>Walker</surname><given-names>J. K.</given-names></name>; <name><surname>Devadas</surname><given-names>B.</given-names></name>; <name><surname>Durley</surname><given-names>R. C.</given-names></name>; <name><surname>Kurumbail</surname><given-names>R.</given-names></name>; <name><surname>Shieh</surname><given-names>H.</given-names></name>; <name><surname>Xing</surname><given-names>L.</given-names></name>; <name><surname>Hepperle</surname><given-names>M.</given-names></name>; <name><surname>Rucker</surname><given-names>P. V.</given-names></name>; <name><surname>Jerome</surname><given-names>K. D.</given-names></name>; <name><surname>Benson</surname><given-names>A. G.</given-names></name>; <name><surname>Marrufo</surname><given-names>L. D.</given-names></name>; <name><surname>Madsen</surname><given-names>H. M.</given-names></name>; <name><surname>Hitchcock</surname><given-names>J.</given-names></name>; <name><surname>Owen</surname><given-names>T. J.</given-names></name>; <name><surname>Christie</surname><given-names>L.</given-names></name>; <name><surname>Promo</surname><given-names>M. A.</given-names></name>; <name><surname>Hickory</surname><given-names>B. S.</given-names></name>; <name><surname>Alvira</surname><given-names>E.</given-names></name>; <name><surname>Naing</surname><given-names>W.</given-names></name>; <name><surname>Blevis-Bal</surname><given-names>R.</given-names></name>; <name><surname>Devraj</surname><given-names>R. V.</given-names></name>; <name><surname>Messing</surname><given-names>D.</given-names></name>; <name><surname>Schindler</surname><given-names>J. F.</given-names></name>; <name><surname>Hirsch</surname><given-names>J.</given-names></name>; <name><surname>Saabye</surname><given-names>M.</given-names></name>; <name><surname>Bonar</surname><given-names>S.</given-names></name>; <name><surname>Webb</surname><given-names>E.</given-names></name>; <name><surname>Anderson</surname><given-names>G.</given-names></name>; <name><surname>Monahan</surname><given-names>J. B.</given-names></name>
<source>Bioorg. Med. Chem. Lett.</source>
<year>2011</year>, <volume>21</volume>, <fpage>4059</fpage>.<pub-id pub-id-type="pmid">21640588</pub-id></mixed-citation></ref><ref id="ref19"><mixed-citation publication-type="journal" id="cit19"><comment>For the preparation
of pyrazolo[3,4-<italic>b</italic>]quinolin-5(4<italic>H</italic>)-ones <bold>9</bold>, see:</comment><name><surname>Hua</surname><given-names>G.-P.</given-names></name>; <name><surname>Xu</surname><given-names>J.-N.</given-names></name>; <name><surname>Tu</surname><given-names>S.-J.</given-names></name>; <name><surname>Wang</surname><given-names>Q.</given-names></name>; <name><surname>Zhang</surname><given-names>J.-P.</given-names></name>; <name><surname>Zhu</surname><given-names>X.-T.</given-names></name>; <name><surname>Li</surname><given-names>T.-J.</given-names></name>; <name><surname>Zhu</surname><given-names>S.-L.</given-names></name>; <name><surname>Zhang</surname><given-names>X.-J.</given-names></name>
<source>Youji Huaxue</source>
<year>2005</year>, <volume>25</volume>, <fpage>1610</fpage>.</mixed-citation></ref></ref-list></back></article>
